{"content":"<li class=\"n-box-item date-title\" data-end=\"1492747199\" data-start=\"1492660800\" data-txt=\"Monday, December 23, 2019\">Thursday, April 20, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3258564\" data-ts=\"1492733177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258564-onconovaminus-12-announces-public-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova -12% as it announces public stock offering</a></h4><ul>   <li>Onconova Therapeutics (<a href=\"http://seekingalpha.com/symbol/ONTX\" target=\"_blank\">ONTX</a> <font color='red'>-5%</font>) has <font color='red'>slid another 12.1%</font> in postmarket trade after <a href=\"https://seekingalpha.com/pr/16806026-onconova-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">announcing a public stock offering</a>.</li>    <li>All shares in the offering will be sold by the company; it will use net proceeds to support development of rigosertib for treatment in higher risk MDS.</li>    <li>It will grant the underwriter a 45-day option to buy up to an additional 15% of shares to cover overallotments.</li>    <li>Laidlaw and co. is acting as sole book-runner.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258564\" data-linked=\"Onconova -12% as it announces public stock offering\" data-tweet=\"$ONTX - Onconova -12% as it announces public stock offering https://seekingalpha.com/news/3258564-onconovaminus-12-announces-public-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3258564-onconovaminus-12-announces-public-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258563\" data-ts=\"1492732982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258563-applied-optoelectronicsplus-2_7-on-move-to-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Optoelectronics +2.7% on move to SmallCap 600</a></h4><ul>   <li>Applied Optoelectronics (<a href=\"http://seekingalpha.com/symbol/AAOI\" target=\"_blank\">AAOI</a> <font color='green'>+1.3%</font>) is <font color='green'>up 2.7%</font> after hours on word it will <a href=\"https://seekingalpha.com/pr/16805972-applied-optoelectronics-set-join-s-and-p-smallcap-600\" target=\"_blank\">join the S&amp;P SmallCap 600</a>.</li>    <li>It's replacing Adeptus Health (<a href=\"http://seekingalpha.com/symbol/ADPT\" target=\"_blank\">ADPT</a> <font color='red'>-4.1%</font>), which has <a href=\"https://seekingalpha.com/news/3258188-adeptus-files-bankruptcy-protection\" target=\"_blank\">filed for Chapter 11</a>.</li>    <li>The move is effective before the open on Tuesday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258563\" data-linked=\"Applied Optoelectronics +2.7% on move to SmallCap 600\" data-tweet=\"$AAOI $AAOI $ADPT-RETIRED - Applied Optoelectronics +2.7% on move to SmallCap 600 https://seekingalpha.com/news/3258563-applied-optoelectronicsplus-2_7-on-move-to-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3258563-applied-optoelectronicsplus-2_7-on-move-to-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258562\" data-ts=\"1492732715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EFII\" target=\"_blank\">EFII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258562-electronics-for-imagingminus-12_6-sales-decline-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Electronics for Imaging -12.6% as sales decline, miss</a></h4><ul>   <li>Electronics for Imaging (<a href=\"http://seekingalpha.com/symbol/EFII\" target=\"_blank\">EFII</a> <font color='green'>+1.2%</font>) has <font color='red'>tumbled 12.6%</font> after hours following a <a href=\"https://seekingalpha.com/news/3258448-electronics-imaging-eps-line-misses-revenue\" target=\"_blank\">Q1 report</a> where sales declined and missed expectations as Americas revenues fell.</li>    <li>&ldquo;To address the challenges we faced in Q1 we are taking steps to better execute on our pipeline, while further leveraging the solid growth in the textile printing business, the start of the Nozomi beta rollout and our new product introductions in the back half of the year,\" says CEO Guy Gecht.</li>    <li>Revenue by segment: Industrial inkjet, $123.3M (down 2%); Productivity software, $35.1M (up 7.7%); Fiery, $70.4M (down 7.2%).</li>    <li>Revenue by geography: Americas, $109.9M (down 8.6%); EMEA, $88M (up 5.3%); APAC, $30.8M (up 1.6%).</li>    <li>Cash and equivalents came to $151.1M, down from last quarter's $164.3M and a year-ago $190.2M. Net cash from operations was $14.9M, up from a year-ago $8.97M.</li>    <li><a href=\"https://seekingalpha.com/pr/16805711-efi-reports-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258562\" data-linked=\"Electronics for Imaging -12.6% as sales decline, miss\" data-tweet=\"$EFII - Electronics for Imaging -12.6% as sales decline, miss https://seekingalpha.com/news/3258562-electronics-for-imagingminus-12_6-sales-decline-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3258562-electronics-for-imagingminus-12_6-sales-decline-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258561\" data-ts=\"1492731817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MANH\" target=\"_blank\">MANH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258561-manhattan-associates-misses-on-revenues-cuts-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manhattan Associates misses on revenues, cuts outlook</a></h4><ul>   <li>Manhattan Associates (NASDAQ:<a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a>) has <font color='red'>slipped 6.1%</font> postmarket after reporting <a href=\"https://seekingalpha.com/news/3258444-manhattan-associates-beats-0_04-misses-revenue\" target=\"_blank\">Q1 earnings</a> where revenues declined and missed expectations, and the company lowered its full-year outlook.</li>    <li>The quarter showed a balance between \"strong license fee performance and retail macro challenges,\" says CEO Eddie Capel.</li>    <li>&ldquo;We expect that retail market headwinds will persist throughout 2017 as many retailers address strategic challenges with enterprise transformation,\" he said.</li>    <li>Adjusted EPS was flat Y/Y, though it beat expectations. Cash from operations was at $61.3M, vs. a year-ago $40.4M. Days sales outstanding was 53 days, vs. 63 days at last quarter's end.</li>    <li>Revenue breakout: Software license, $22.8M (up 10.5%); Services, $108.8M (down 6.4%); Hardware and other, $11.9M (down 8.5%).</li>    <li>It's trimmed full-year guidance on revenues to $606M-$620M (flat to 3% growth, and below consensus for $624.5M) from a previous $622M-$632M. It reiterated guidance for adjusted EPS of $1.89-$1.93, vs. consensus for $1.91.</li>    <li><a href=\"https://seekingalpha.com/pr/16805734-manhattan-associates-reports-first-quarter-2017-performance\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258561\" data-linked=\"Manhattan Associates misses on revenues, cuts outlook\" data-tweet=\"$MANH - Manhattan Associates misses on revenues, cuts outlook https://seekingalpha.com/news/3258561-manhattan-associates-misses-on-revenues-cuts-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3258561-manhattan-associates-misses-on-revenues-cuts-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258560\" data-ts=\"1492729263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258560-for-switch-videogame-sales-jump-thanks-to-nintendo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">For a switch, videogame sales jump, thanks to Nintendo</a></h4><ul>   <li>After months of declines, videogame sales rebounded in March with the help of a new console from Nintendo (<a href=\"http://seekingalpha.com/symbol/NTDOY\" target=\"_blank\">NTDOY</a> <font color='red'>-1.4%</font>) and some strong game releases.</li>    <li>Overall sales jumped 24% to $1.36B, according to NPD Group, halting a streak of nine straight Y/Y declines in the business. Hardware sales nearly doubled, to $485M, as the Nintendo Switch had the second-biggest launch for any platform in more than 20 years.</li>    <li>Accesories grew 9% to $231M, with Switch accessories making up a quarter of that. An Amiibo character pack tied to <i>The Legend of Zelda: Breath of the Wild</i> made up 43% of spending on interactive gaming toys.</li>    <li>In software, videogame software rose 5% to $612M, and PC game software (physical and via Steam) fell 25% to $29M, leading to total software gains of 2.7%. A set of new releases topped the game charts and spurred sales: <i>Tom Clancy's Ghost Recon: Wildlands</i> (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='green'>+2.6%</font>) debuted at the top of the dollar sales chart, followed by the new <i>Zelda</i> (<a href='https://seekingalpha.com/symbol/NTDOY' title='Nintendo Co., Ltd. ADR'>OTCPK:NTDOY</a>). No. 3 was <i>Mass Effect: Andromeda</i> (<a href=\"http://seekingalpha.com/symbol/EA\" target=\"_blank\">EA</a> <font color='green'>+1.7%</font>) and No. 4, <i>Horizon Zero Dawn</i> (<a href=\"http://seekingalpha.com/symbol/SNE\" target=\"_blank\">SNE</a> <font color='green'>+2.6%</font>).</li>    <li>The Switch version of <i>Zelda</i> sold more than 900,000 packaged units and Switch packaged software overall sold 1.3M, a record for a Nintendo launch.</li>    <li>The top 10 in software rounded out: No. 5, <i>MLB 17: The Show</i> (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>); No. 6, <i>Grand Theft Auto V</i> (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='green'>+2.6%</font>); No. 7, <i>For Honor</i> (<a href='https://seekingalpha.com/symbol/UBSFY' title='UbiSoft Entertainment Inc. ADR'>OTCPK:UBSFY</a>); No. 8, <i>NBA 2K17</i> (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>); No. 9, <i>Nier: Automata</i> (Square Enix); No. 10, <i>Call of Duty: Infinite Warfare</i> (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='green'>+1.2%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258560\" data-linked=\"For a switch, videogame sales jump, thanks to Nintendo\" data-tweet=\"$NTDOY $NTDOY $SNE - For a switch, videogame sales jump, thanks to Nintendo https://seekingalpha.com/news/3258560-for-switch-videogame-sales-jump-thanks-to-nintendo?source=tweet\" data-url=\"https://seekingalpha.com/news/3258560-for-switch-videogame-sales-jump-thanks-to-nintendo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258549\" data-ts=\"1492725300\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFPT\" target=\"_blank\">PFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258549-proofpoint-rebounds-7_4-after-beat-raised-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proofpoint rebounds 7.4% after beat, raised guidance</a></h4><ul>   <li>After a daylong tumble, security/compliance firm Proofpoint (<a href=\"http://seekingalpha.com/symbol/PFPT\" target=\"_blank\">PFPT</a> <font color='red'>-8.5%</font>) is bouncing back after hours, <font color='green'>+7.4%</font>, following a <a href=\"https://seekingalpha.com/news/3258441-proofpoint-beats-0_03-beats-revenue\" target=\"_blank\">Q1 earnings beat</a> that featured 2017 guidance boosted above expectations.</li>    <li>Revenues rose 43% on billings that increased 40% to $137.4M. The company swung to an operating profit of $7.1M on a non-GAAP basis, vs. a year-ago loss of $2.5M.</li>    <li>Revenue breakout: Subscription, $110.9M (up 43.3%); Hardware and services, $2.3M (up 44.8%).</li>    <li>For Q2, it's guiding to revenue of $118M-$120M (vs. consensus for $118.2M), with billings expected at $141M-$143M, and non-GAAP EPS of $0.11-$0.13 vs. an expected $0.11, along with free cash flow of $11M-$12M.</li>    <li>For full 2017, it sees revenues of $496M-$500M (above consensus for $492.3M), with billings at $619M-$623M. Non-GAAP EPS is forecast at $0.56-$0.59 vs. $0.51 expected, and free cash flow is forecast at $98M-$106M.</li>    <li><a href=\"https://seekingalpha.com/pr/16805737-proofpoint-announces-first-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258549\" data-linked=\"Proofpoint rebounds 7.4% after beat, raised guidance\" data-tweet=\"$PFPT - Proofpoint rebounds 7.4% after beat, raised guidance https://seekingalpha.com/news/3258549-proofpoint-rebounds-7_4-after-beat-raised-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3258549-proofpoint-rebounds-7_4-after-beat-raised-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258544\" data-ts=\"1492724316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATRA\" target=\"_blank\">ATRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258544-atara-biotherapeuticsplus-8_7-on-results-from-early-stage-trial-of-ms-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atara Biotherapeutics +8.7% on results from early stage trial of MS drug</a></h4><ul><li>Atara Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a>)&nbsp;<font color='green'>+8.7%</font>&nbsp;AH after reporting <a href=\"https://seekingalpha.com/pr/16805804-atara-bio-announces-positive-interim-results-ongoing-phase-1-trial-autologous-version-ata188\" target=\"_blank\">positive results</a> from a Phase 1 clinical trial of its multiple sclerosis drug.</li><li>ATRA says the trial showed the autologous version of its ATA188 drug was well  tolerated in patients with primary and secondary progressive multiple sclerosis, and that half experienced improvements in their  symptoms.</li><li>ATRA says test results showed encouraging clinical improvements through 26 weeks correlating with EBV  reactivity.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258544\" data-linked=\"Atara Biotherapeutics +8.7% on results from early stage trial of MS drug\" data-tweet=\"$ATRA - Atara Biotherapeutics +8.7% on results from early stage trial of MS drug https://seekingalpha.com/news/3258544-atara-biotherapeuticsplus-8_7-on-results-from-early-stage-trial-of-ms-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3258544-atara-biotherapeuticsplus-8_7-on-results-from-early-stage-trial-of-ms-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258543\" data-ts=\"1492724254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258543-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color='green'>+15.3%</font>. <a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a> <font color='green'>+8.7%</font>. <a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a> <font color='green'>+8.3%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='green'>+5.7%</font>. <a href='https://seekingalpha.com/symbol/NMM' title='Navios Maritime Partners L.P.'>NMM</a> <font color='green'>+5.5%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/EFII' title='Electronics for Imaging, Inc.'>EFII</a> <font color='red'>-11.2%</font>. <a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a> <font color='red'>-6.3%</font>. <a href='https://seekingalpha.com/symbol/MANH' title='Manhattan Associates, Inc.'>MANH</a> <font color='red'>-6.1%</font>. <a href='https://seekingalpha.com/symbol/GPT' title='Gramercy Property Trust, Inc.'>GPT</a> <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/VLRS' title='Volaris Aviation'>VLRS</a> <font color='red'>-3.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258543\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$VBLT $ATRA $PFPT - After Hours Gainers / Losers https://seekingalpha.com/news/3258543-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3258543-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258542\" data-ts=\"1492723914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NCR\" target=\"_blank\">NCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258542-ncr-drops-in-late-trade-despite-beat-raised-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NCR drops in late trade despite beat, raised guidance</a></h4><ul>   <li>NCR (<a href=\"http://seekingalpha.com/symbol/NCR\" target=\"_blank\">NCR</a> <font color='green'>+2.8%</font>) is giving up gains after hours, <font color='red'>-2.5%</font>, despite <a href=\"https://seekingalpha.com/news/3258462-ncr-beats-0_10-beats-revenue\" target=\"_blank\">posting Q1 results</a> that beat expectations and featured raised guidance.</li>    <li>Revenue grew 2.3% to $1.48B, up 9% excluding currency effects and the IPS divestiture. Gross margin was up 9% to $413M, thanks to a favorable software mix and productivity improvement.</li>    <li>Operating income rose 16% to $117M.</li>    <li>Revenue by segment: Software, $452M (up 8%); Services, $557M (up 3%); Hardware, $469M (down 3%).</li>    <li>Cash from operations was $43M, up from $23M; free cash outflow decreased to $12 from a year-ago $29M.</li>    <li>It's boosted fiscal 2017 guidance slightly, to revenues of $6.63B-$6.75B (consensus for $6.68B) from $6.6B-$6.72B, and to non-GAAP EPS of $3.32-$3.42 (above consensus for $3.31) from $3.27-$3.37.</li>    <li><a href=\"https://seekingalpha.com/article/4063909-ncr-corporation-2017-q1-results-earnings-call-slides\" target=\"_blank\">Earnings slides</a></li>    <li><a href=\"https://seekingalpha.com/pr/16805778-ncr-announces-first-quarter-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258542\" data-linked=\"NCR drops in late trade despite beat, raised guidance\" data-tweet=\"$NCR - NCR drops in late trade despite beat, raised guidance https://seekingalpha.com/news/3258542-ncr-drops-in-late-trade-despite-beat-raised-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3258542-ncr-drops-in-late-trade-despite-beat-raised-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258515\" data-ts=\"1492721237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258515-maxim-integrated-up-after-fiscal-q3-beat-solid-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim Integrated up after fiscal Q3 beat, solid guidance</a></h4><ul>   <li>Maxim Integrated Products (<a href=\"http://seekingalpha.com/symbol/MXIM\" target=\"_blank\">MXIM</a> <font color='green'>+1.9%</font>) is <font color='green'>up 1.4%</font> in choppy after-hours trades following <a href=\"https://seekingalpha.com/news/3258461-maxim-integrated-products-beats-0_03-beats-revenue\" target=\"_blank\">Q3 earnings</a> that beat expectations and featured solid guidance for the June quarter.</li>    <li>Results were paced by Automotive and Industrial growth year-over-year, says CEO Tunc Doluca.</li>    <li>Cash, equivalents and short-term investments were $2.16B, up $69M Q/Q. Cash flow from operations was $221M.</li>    <li>Based on a 90-day backlog of $382M, Maxim's guiding for next-quarter revenues of $590M-$630M (vs. consensus for $598M) and non-GAAP EPS of $0.59-$0.65 (above expectations for $0.58).</li>    <li><a href=\"http://investor.maximintegrated.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16805706-maxim-integrated-reports-results-third-quarter-fiscal-2017\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258515\" data-linked=\"Maxim Integrated up after fiscal Q3 beat, solid guidance\" data-tweet=\"$MXIM - Maxim Integrated up after fiscal Q3 beat, solid guidance https://seekingalpha.com/news/3258515-maxim-integrated-up-after-fiscal-q3-beat-solid-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3258515-maxim-integrated-up-after-fiscal-q3-beat-solid-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258512\" data-ts=\"1492721030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VBLT\" target=\"_blank\">VBLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258512-vbls-late-stage-study-of-vbminus-111-in-brain-cancer-to-continue-planned-after-safety-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VBL&#39;s late-stage study of VB-111 in brain cancer to continue as planned after safety review; shares ahead 16% after hours</a></h4><ul><li>Thinly traded micro cap VBL Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a>) is up&nbsp;<font color='green'>16%</font>&nbsp;after hours on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16805677-vbl-therapeutics-announces-positive-dsmc-review-phase-3-globe-trial-investigating-vbminus-111\" target=\"_blank\">announcement </a>that, after a review of the safety data by the Independent Data Safety Monitoring Committee, its Phase 3 clinical trial, GLOBE, assessing lead product candidate ofranergene obadenovec (VB-111) in recurrent glioblastoma will continue as planned.</li><li>Interim efficacy data will be available this summer with top-line results from the full dataset expected in early 2018.</li><li><a href=\"http://www.vblrx.com/cancer-programs/cancer-pipline/\" target=\"_blank\">VB-111</a>&nbsp;is an intravenously-administered next-generation anti-angiogenic agent that utilizes the company's&nbsp;<a href=\"http://www.vblrx.com/cancer-programs/cancer-platform/\" target=\"_blank\">Vascular Targeting System&nbsp;</a>to target endothelial cells in the tumor vasculature.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258512\" data-linked=\"VBL&#39;s late-stage study of VB-111 in brain cancer to continue as planned after safety review; shares ahead 16% after hours\" data-tweet=\"$VBLT - VBL&#39;s late-stage study of VB-111 in brain cancer to continue as planned after safety review; shares ahead 16% after hours https://seekingalpha.com/news/3258512-vbls-late-stage-study-of-vbminus-111-in-brain-cancer-to-continue-planned-after-safety-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3258512-vbls-late-stage-study-of-vbminus-111-in-brain-cancer-to-continue-planned-after-safety-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258509\" data-ts=\"1492720978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258509-sell-side-comes-to-new-residential-defense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side comes to New Residential defense</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3258405-mixed-action-servicers-ocwen-plunges\" target=\"_blank\">Sucked into the Ocwen Financial vortex</a> today, New Residential (NYSE:<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>) was down as much<font color='red'> as 13%</font>&nbsp;before closing the regular session&nbsp;<font color='red'>off 7.65%</font>.</li><li>To review, Ocwen handles the servicing for a sizable number of MSRs owned by New Residential (New Residential takes care of the excess servicing). Presumably, New Residential could move servicing elsewhere were something bad to happen to Ocwen.</li><li>Citi came out in defense of NRZ shortly before the close, and now comes FBR's Jessica Levi-Ribner, telling clients to buy NRZ on the overreaction to the Ocwen news. It's possible, she says, New Residential has already begun transferring servicing rights to its own name, thus protecting it from counter-party risk.</li><li>Source: Bloomberg</li><li>Shares are&nbsp;<font color='green'>higher by 1%</font>&nbsp;after hours. Ocwen (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) is&nbsp;<font color='green'>up 9.25%</font>&nbsp;after hours, following a&nbsp;<font color='red'>53.9% plunge</font>&nbsp;in the regular session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258509\" data-linked=\"Sell-side comes to New Residential defense\" data-tweet=\"$NRZ $NRZ $OCN - Sell-side comes to New Residential defense https://seekingalpha.com/news/3258509-sell-side-comes-to-new-residential-defense?source=tweet\" data-url=\"https://seekingalpha.com/news/3258509-sell-side-comes-to-new-residential-defense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>96&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258490\" data-ts=\"1492720330\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETFC\" target=\"_blank\">ETFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258490-e-trade-climbs-2_8-after-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E*Trade climbs 2.8% after earnings beat</a></h4><ul><li>Q1 net income of $145M or $0.48 per share not necessarily comparable to income of $153M and $0.53 a year ago. Net revenue of $553M up from $472M.</li><li>Adjusted operating margin of 38% up 400 basis points Y/Y.</li><li>Net interest margin of 263 bps down 18 bps; interest-earning assets of $48.7B up 19%.</li><li>DARTs of 207.2K up 25% from Q1 one year ago. Average commission per trade of $9.87 down 7%. Customer margin balances of $7.3B up 16%.</li><li>Loan loss provision benefit of $14M for quarter vs. benefit of $18M a year ago.</li><li><a href=\"http://about.etrade.com\" target=\"_blank\">Conference call at 5 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3258445-e-trade-financial-beats-0_09-beats-revenue\" target=\"_blank\">E*TRADE Financial beats by $0.09, beats on revenue</a> (April 20)</li><li><a href='https://seekingalpha.com/symbol/ETFC' title='E*TRADE Financial Corporation'>ETFC</a>&nbsp;<font color='green'>+2.8%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3258490\" data-linked=\"E*Trade climbs 2.8% after earnings beat\" data-tweet=\"$ETFC - E*Trade climbs 2.8% after earnings beat https://seekingalpha.com/news/3258490-e-trade-climbs-2_8-after-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3258490-e-trade-climbs-2_8-after-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258480\" data-ts=\"1492719930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMP\" target=\"_blank\">ADMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258480-adamis-pharma-readies-equity-offering-shares-down-17-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adamis Pharma readies equity offering; shares down 17% after hours</a></h4><ul><li>Adamis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a>) slumps&nbsp;<font color='red'>17%</font>&nbsp;after hours on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16805671-adamis-pharmaceuticals-announces-proposed-public-offering-common-stock\" target=\"_blank\">planned equity offering</a>. Price, volume and terms have yet to be announced. Net proceeds will be used for general corporate purposes.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258480\" data-linked=\"Adamis Pharma readies equity offering; shares down 17% after hours\" data-tweet=\"$ADMP - Adamis Pharma readies equity offering; shares down 17% after hours https://seekingalpha.com/news/3258480-adamis-pharma-readies-equity-offering-shares-down-17-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3258480-adamis-pharma-readies-equity-offering-shares-down-17-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258479\" data-ts=\"1492719913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAT\" target=\"_blank\">MAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258479-inventory-overhang-whacks-bottom-line-mattel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inventory overhang whacks bottom line at Mattel</a></h4><ul>     <li>Mattel (NASDAQ:<a href='https://seekingalpha.com/symbol/MAT' title='Mattel, Inc.'>MAT</a>) is&nbsp;<font color='red'>down 4.20%</font>&nbsp;in AH trading after the toy company misses estimates with its <a href=\"https://seekingalpha.com/pr/16805746-mattel-reports-first-quarter-2017-financial-results-declares-quarterly-dividend\" target=\"_blank\">Q1 report</a>.</li>     <li>Global Barbie sales fell 13% during the quarter, while Fischer-Price sales fell 9%.</li>     <li>The company's gross margin rate came in at 37.9%, well below the consensus estimate for a mark of 43.1%.</li>     <li>\"Results were below our expectations due to the retail inventory overhang coming out of the holiday period,\" warns CEO Margo Georgiadis.</li>     <li>\"We are confident we have worked through the majority of this overhang and look forward to a strong launch of Disney's Cars 3 theatrical release in the second quarter,\" she adds.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258457-mattel-misses-0_15-misses-revenue\" target=\"_blank\">Mattel misses by $0.15, misses on revenue</a> (April 20)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258479\" data-linked=\"Inventory overhang whacks bottom line at Mattel\" data-tweet=\"$MAT - Inventory overhang whacks bottom line at Mattel https://seekingalpha.com/news/3258479-inventory-overhang-whacks-bottom-line-mattel?source=tweet\" data-url=\"https://seekingalpha.com/news/3258479-inventory-overhang-whacks-bottom-line-mattel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258466\" data-ts=\"1492719472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258466-visa-higher-after-earnings-5b-buyback-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Visa higher after earnings, $5B buyback plan</a></h4><ul>     <li>Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>) reports payments volume growth of 37% to $1.7T in <a href=\"https://seekingalpha.com/pr/16805729-visa-inc-reports-strong-fiscal-second-quarter-2017-results-announces-new-5_0-billion-share\" target=\"_blank\">FQ2</a>.</li>     <li>Cross-border volume was up 132% Y/Y during the quarter, inclusive of the new contribution of Visa Europe.</li>     <li>Total processed transactions jumped up 42% to 26.3B.</li>     <li>Services revenue was up 17% to $2.0B.</li>     <li>Visa's effective tax rate was 28.6% for the quarter.</li>     <li>Looking ahead, Visa expects revenue growth of 16% to 18% for the fiscal year on an adjusted basis. Annual operating margin in the mid 60s and an adjusted effective tax rate of around 30% are anticipated.</li><li>The company says it will buy back up to $5B worth of it stock.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3258443-visa-beats-0_07-beats-revenue\" target=\"_blank\">Visa beats by $0.07, beats on revenue</a> (April 20)</li>     <li>V&nbsp;<font color='green'>+3.07%</font>&nbsp;AH to $93.95.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258466\" data-linked=\"Visa higher after earnings, $5B buyback plan\" data-tweet=\"$V - Visa higher after earnings, $5B buyback plan https://seekingalpha.com/news/3258466-visa-higher-after-earnings-5b-buyback-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3258466-visa-higher-after-earnings-5b-buyback-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258461\" data-ts=\"1492719202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258461-maxim-integrated-products-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxim Integrated Products beats by $0.03, beats on revenue</a></h4><ul><li>Maxim Integrated Products (NASDAQ:<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a>): Q3 EPS of $0.56 <font color='green'>beats by $0.03</font>.</li><li>Revenue of $581.21M (+4.7% Y/Y) <font color='green'>beats by $5.48M</font>.</li><li>Shares <font color='green'>+2.2%</font>.</li><li><a href='https://seekingalpha.com/pr/16805706-maxim-integrated-reports-results-third-quarter-fiscal-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258461\" data-linked=\"Maxim Integrated Products beats by $0.03, beats on revenue\" data-tweet=\"$MXIM - Maxim Integrated Products beats by $0.03, beats on revenue https://seekingalpha.com/news/3258461-maxim-integrated-products-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3258461-maxim-integrated-products-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258450\" data-ts=\"1492718979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258450-skechers-tops-1b-in-revenue-sharesplus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers tops $1B in revenue, shares +4%</a></h4><ul>     <li>Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) hauls in more than <a href=\"https://seekingalpha.com/pr/16805661-skechers-announces-first-billion-dollar-plus-quarter\" target=\"_blank\">$1B</a> for the first time ever in a quarter.</li>     <li>The company says it recorded a 16.8% revenue increase in its international wholesale business and a 12.8% gain for its company-owned global retail business.</li>     <li>Gross profit improved 20 bps to 44.4% of sales.</li>     <li>Selling expenses rose 140 bps to 6.9% of sales.</li>     <li>The company ended the quarter with an inventory position of $586M, up 17% Y/Y.</li>     <li>Skechers sees revenue of $950M-$975M in Q2 vs. $962M consensus and EPS of $0.42 to $0.47 vs. $0.47 consensus.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3258433-skechers-beats-0_06-beats-revenue\" target=\"_blank\">Skechers beats by $0.06, beats on revenue</a> (April 20)</li>     <li>SKX&nbsp;<font color='green'>+4.40%</font>&nbsp;AH to $27.41.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258450\" data-linked=\"Skechers tops $1B in revenue, shares +4%\" data-tweet=\"$SKX - Skechers tops $1B in revenue, shares +4% https://seekingalpha.com/news/3258450-skechers-tops-1b-in-revenue-sharesplus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3258450-skechers-tops-1b-in-revenue-sharesplus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258443\" data-ts=\"1492718813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/V\" target=\"_blank\">V</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258443-visa-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Visa beats by $0.07, beats on revenue</a></h4><ul><li>Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>): Q2 EPS of $0.86 <font color='green'>beats by $0.07</font>.</li><li>Revenue of $4.47B (+23.1% Y/Y) <font color='green'>beats by $160M</font>.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16805729-visa-inc-reports-strong-fiscal-second-quarter-2017-results-announces-new-5_0-billion-share'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258443\" data-linked=\"Visa beats by $0.07, beats on revenue\" data-tweet=\"$V - Visa beats by $0.07, beats on revenue https://seekingalpha.com/news/3258443-visa-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3258443-visa-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258438\" data-ts=\"1492718681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HA\" target=\"_blank\">HA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258438-hawaiian-holdings-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hawaiian Holdings beats by $0.19, beats on revenue</a></h4><ul><li>Hawaiian Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a>): Q1 EPS of $1.04 <font color='green'>beats by $0.19</font>.</li><li>Revenue of $614.19M (+11.4% Y/Y) <font color='green'>beats by $3.47M</font>.</li><li>Shares <font color='green'>+2.12%</font>.</li><li><a href='https://seekingalpha.com/pr/16805666-hawaiian-holdings-reports-2017-first-quarter-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258438\" data-linked=\"Hawaiian Holdings beats by $0.19, beats on revenue\" data-tweet=\"$HA - Hawaiian Holdings beats by $0.19, beats on revenue https://seekingalpha.com/news/3258438-hawaiian-holdings-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3258438-hawaiian-holdings-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258425\" data-ts=\"1492717435\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTR\" target=\"_blank\">FTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258425-fcc-votes-to-deregulate-business-data-services-portending-price-hikes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FCC votes to deregulate business data services, portending price hikes</a></h4><ul>   <li>As expected, the FCC has voted to do away with most regulations of the $45B business data services market, effectively <a href=\"http://www.reuters.com/article/us-usa-fcc-data-idUSKBN17M1ZO?il=0\" target=\"_blank\">deregulating the business</a> and likely paving the way for price hikes on small business (and schools and libraries) from telecom giants.</li>    <li>The rich are set to get richer: AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+0.2%</font>), Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='red'>-1.3%</font>), CenturyLink (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='green'>+0.7%</font>). But some companies like Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='green'>+0.2%</font>) backed the old plan, saying prices for business data are too high.</li>    <li>Small businesses and government services need special access lines to quickly transmit large amounts of data, such as to ATM readers or credit-card gas pumps.</li>    <li>The move today isn't a complete deregulation, as a few price caps in areas with little competition will be kept. FCC Chairman Ajit Pai said the regulations had threatened competition and investment.</li>    <li>Other BDS players: <a href='https://seekingalpha.com/symbol/FTR' title='Frontier Communications Corporation'>FTR</a> <font color='green'>+4.3%</font>, <a href='https://seekingalpha.com/symbol/BT' title='BT Group plc'>BT</a> <font color='green'>+0.5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258425\" data-linked=\"FCC votes to deregulate business data services, portending price hikes\" data-tweet=\"$FTR $FTR $BT - FCC votes to deregulate business data services, portending price hikes https://seekingalpha.com/news/3258425-fcc-votes-to-deregulate-business-data-services-portending-price-hikes?source=tweet\" data-url=\"https://seekingalpha.com/news/3258425-fcc-votes-to-deregulate-business-data-services-portending-price-hikes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258423\" data-ts=\"1492717074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258423-sinking-feeling-for-rite-aid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinking feeling for Rite Aid</a></h4><ul><li>Rite Aid (<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a> <font color='red'>-2.3%</font>) and Fred's (<a href='https://seekingalpha.com/symbol/FRED' title='Fred&#39;s, Inc.'>FRED</a> <font color='red'>-1.2%</font>) are lower again on more concerns that the FTC will sue to prevent Rite Aid's merger with Walgreens. The latest reports via Bloomberg indicate the agency is deposing execs at Rite Aid.</li><li>Imperial Capital didn't help Rite Aid shareholders a whole lot earlier today when it noted that the standalone value of the company is about $1.50 or $2.00 to $3.00 if the improvement in the Wellness stores is factored in.</li><li>Sources: CNBC and Bloomberg</li><li>Shares of Rite Aid hit a 52-week low of $3.75 earlier in the afternoon.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258423\" data-linked=\"Sinking feeling for Rite Aid\" data-tweet=\"$RAD $RAD $FRED - Sinking feeling for Rite Aid https://seekingalpha.com/news/3258423-sinking-feeling-for-rite-aid?source=tweet\" data-url=\"https://seekingalpha.com/news/3258423-sinking-feeling-for-rite-aid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>111&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258421\" data-ts=\"1492716772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258421-ocwen-cfpb-suit-unfounded-sharesminus-52\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen: CFPB suit unfounded; shares -52%</a></h4><ul><li>\"The substantive allegations in today&rsquo;s suit are inaccurate and unfounded,\" <a href=\"https://seekingalpha.com/pr/16805569-ocwen-prepared-vigorously-defend-cfpb-bureau-s-action-ignores-critical-facts-will-harm\" target=\"_blank\">says</a> Ocwen Financial (<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='red'>-52%</font>), responding to today's CFPB charges. Ocwen is \"unaware\" of the CFPB conducting any detailed review of its loan servicing files.</li><li>\"The CFPB suit is primarily based on the CFPB&rsquo;s flawed review of data and its self-serving conclusion about isolated instances where Ocwen self-identified ways we can do better.\"</li><li>In between the lines of the Ocwen response: The head of the CFPB (if not the whole agency) has been targeted for firing by the Trump administration, and what better way to stay in business than to unleash a lawsuit against a fat target.</li><li>Maybe the bigger issue for Ocwen are cease and desist orders from regulators in more than 20 states. The company intends to respond later.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258396-ocwen-now-40-percent-investors-debate-endgame\" target=\"_blank\">Ocwen now down 40% as investors debate endgame</a> (April 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258421\" data-linked=\"Ocwen: CFPB suit unfounded; shares -52%\" data-tweet=\"$OCN - Ocwen: CFPB suit unfounded; shares -52% https://seekingalpha.com/news/3258421-ocwen-cfpb-suit-unfounded-sharesminus-52?source=tweet\" data-url=\"https://seekingalpha.com/news/3258421-ocwen-cfpb-suit-unfounded-sharesminus-52\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258415\" data-ts=\"1492714857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258415-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ALSK' title='Alaska Communications Systems Group, Inc.'>ALSK</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BMI' title='Badger Meter, Inc.'>BMI</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/INVA' title='Innoviva, Inc.'>INVA</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PLXS' title='Plexus Corp.'>PLXS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/PFPT' title='Proofpoint, Inc.'>PFPT</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258415\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$VHC $DWCH $MVIS - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3258415-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258415-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258414\" data-ts=\"1492714576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEA\" target=\"_blank\">LEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258414-lear-upgraded-baird-after-lagging-for-months\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lear upgraded at Baird after lagging for months</a></h4><ul><li>Lear (<a href='https://seekingalpha.com/symbol/LEA' title='Lear Corporation'>LEA</a> <font color='green'>+2.7%</font>) is flying higher as Baird <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9322696/lear-receives-another-bullish-rating-following-months-of\" target=\"_blank\">upgrades</a> shares to Outperform from Neutral with a $161 price target, as the firm has become buyers following sustained underperformance despite strong  company and industry fundamentals.</li><li>Baird says LEA trades at  4.8x estimated 2017 EBITDA, below the company's three-year median of 5.6x, and expects continued strong organic growth above market and free cash flow generation and deployment to support a higher valuation with mid-term upside  toward the auto supplier group's ~6.5x EBITDA.</li><li>Baird also says sell-side sentiment has worsened in recent months, with only around a third of analysts Buy-rated.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258414\" data-linked=\"Lear upgraded at Baird after lagging for months\" data-tweet=\"$LEA - Lear upgraded at Baird after lagging for months https://seekingalpha.com/news/3258414-lear-upgraded-baird-after-lagging-for-months?source=tweet\" data-url=\"https://seekingalpha.com/news/3258414-lear-upgraded-baird-after-lagging-for-months\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258406\" data-ts=\"1492712048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APD\" target=\"_blank\">APD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258406-air-products-india-jv-to-build-six-new-air-separation-plants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Air Products&#39; India JV to build six new air separation plants</a></h4><ul>     <li>Air Products (<a href='https://seekingalpha.com/symbol/APD' title='Air Products and Chemicals, Inc.'>APD</a> <font color='green'>+1.5%</font>) says its India joint venture will invest more than $100M to <a href=\"https://seekingalpha.com/pr/16805424-air-products-india-joint-venture-build-six-new-air-separation-plants\" target=\"_blank\">build six new air separation  units</a>.</li>     <li>APD says the plants will further strengthen its leadership position in India's merchant industrial gases market.</li>     <li>The six plants, which will have a combined capacity of more than 1,200 metric tons/day of liquid product, are scheduled to come onstream during 2018-19.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258406\" data-linked=\"Air Products&#39; India JV to build six new air separation plants\" data-tweet=\"$APD - Air Products&#39; India JV to build six new air separation plants https://seekingalpha.com/news/3258406-air-products-india-jv-to-build-six-new-air-separation-plants?source=tweet\" data-url=\"https://seekingalpha.com/news/3258406-air-products-india-jv-to-build-six-new-air-separation-plants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258405\" data-ts=\"1492711912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRZ\" target=\"_blank\">NRZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258405-mixed-action-in-servicers-ocwen-plunges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mixed action in other servicers as Ocwen plunges</a></h4><ul><li>Regulators have seemingly had their fill with at least the management at Ocwen Financial, if not the company itself. But who exactly is going to service all these mortgages?</li><li>With Ocwen&nbsp;<font color='red'>down 60%</font>, shorts are turning their attention New Residential (<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a> <font color='red'>-12.6%</font>) for the moment. Nationstar Mortgage (<a href='https://seekingalpha.com/symbol/NSM' title='Nationstar Mortgage Holdings'>NSM</a> <font color='green'>+0.1%</font>) and Walter Investment (WAC <font color='red'>-1.4%</font>) are interested parties as well.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258396-ocwen-now-40-percent-investors-debate-endgame\" target=\"_blank\">Ocwen now down 40% as investors debate endgame</a> (April 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258405\" data-linked=\"Mixed action in other servicers as Ocwen plunges\" data-tweet=\"$NRZ $NRZ $NSM - Mixed action in other servicers as Ocwen plunges https://seekingalpha.com/news/3258405-mixed-action-in-servicers-ocwen-plunges?source=tweet\" data-url=\"https://seekingalpha.com/news/3258405-mixed-action-in-servicers-ocwen-plunges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>143&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258403\" data-ts=\"1492711503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258403-stocks-up-1-in-afternoon-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks up 1% in afternoon action</a></h4><ul><li>The Dow and Nasdaq are&nbsp;<font color='green'>ahead 1%</font>&nbsp;and the S&amp;P 500 nearly that much as earnings season begins to get busy. Leading the way for the Dow is a&nbsp;<font color='green'>5.7% advance</font>&nbsp;for AmEx after its earnings beat.</li><li>U.S. Steel is&nbsp;<font color='green'>up more than 8%</font>&nbsp;after the President orders an <a href=\"https://seekingalpha.com/news/3258345-trump-revive-1962-law-investigate-steel-imports\" target=\"_blank\">investigation into overseas steel products</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258403\" data-linked=\"Stocks up 1% in afternoon action\" data-tweet=\"Stocks up 1% in afternoon action https://seekingalpha.com/news/3258403-stocks-up-1-in-afternoon-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3258403-stocks-up-1-in-afternoon-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258401\" data-ts=\"1492711280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258401-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/SXC' title='SunCoke Energy'>SXC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/SXCP' title='SunCoke Energy Partners'>SXCP</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/TGB' title='Taseko Mines Limited'>TGB</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GPRK' title='GeoPark Ltd.'>GPRK</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258401\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$NADL $SXC $SXCP - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3258401-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258401-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258397\" data-ts=\"1492710235\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258397-aig-jumps-2-on-rumor-of-ceo-replacement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG jumps 2% on rumor of CEO replacement</a></h4><ul><li>According to Bloomberg's Daniel Kraut, <a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a> is considering Hamilton Insurance Group Chairman and CEO Brian Duperreault as the replacement for outgoing CEO Peter Hancock.</li><li>The stock's now&nbsp;<font color='green'>higher by 2.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258397\" data-linked=\"AIG jumps 2% on rumor of CEO replacement\" data-tweet=\"$AIG - AIG jumps 2% on rumor of CEO replacement https://seekingalpha.com/news/3258397-aig-jumps-2-on-rumor-of-ceo-replacement?source=tweet\" data-url=\"https://seekingalpha.com/news/3258397-aig-jumps-2-on-rumor-of-ceo-replacement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258396\" data-ts=\"1492709752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258396-ocwen-now-down-40-investors-debate-endgame\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen now down 40% as investors debate endgame</a></h4><ul><li>A closer read of the North Carolina cease and desist order finds Ocwen (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) last December entered into a MOU with a number of state regulators for an audit of all consumer escrow accounts.</li><li>Coming back on Jan. 13, Ocwen said a reconciliation of escrow accounts would cost $1.5B - money the company doesn't have. The company asked to instead audit only a sampling of its 2.5M active first lien escrow accounts. This request was rejected.</li><li>Reports say 20 other state regulators have joined with NC, and other reports are saying the CFPB has sued Ocwen over servicing practices.</li><li>The stock's now&nbsp;<font color='red'>lower by 40%</font>, with sizable vendor Altisource Portfolio Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/ASPS' title='Altisource Portfolio Solutions SA'>ASPS</a>)&nbsp;<font color='red'>down 30%</font>. Altisource Asset Management (<a href='https://seekingalpha.com/symbol/AAMC' title='Altisource Asset Management Corp'>AAMC</a><font color='red'> -7.9%</font>), Altisource Residential (<a href='https://seekingalpha.com/symbol/RESI' title='Front Yard Residential Corporation'>RESI</a> <font color='red'>-3.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258382-ocwen-crumbles-regulatory-issues\" target=\"_blank\">Ocwen crumbles on more regulatory issues</a> (April 20)</li><li><strong>Update at 1:47 ET:</strong> Now<font color='red'> down 53.3%</font>, Ocwen is on volatility halt. ASPS is&nbsp;<font color='red'>off 39%</font>.</li><li>Update at 1:50 ET: Florida Attorney General Pam Bondi gets in on the action, <a href=\"http://www.myfloridalegal.com/newsrel.nsf/newsreleases/975B9DF2B52BB823852581080060D1A2\" target=\"_blank\">filing a lawsuit </a>against Ocwen. <a href=\"http://www.reuters.com/article/ocwen-financial-cfpb-idUSL1N1HS1H8\" target=\"_blank\">According to Reuters</a>, the CFPB has also sued, alleging years of \"widespread errors, shortcuts, and runarounds.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3258396\" data-linked=\"Ocwen now down 40% as investors debate endgame\" data-tweet=\"$OCN $OCN $ASPS - Ocwen now down 40% as investors debate endgame https://seekingalpha.com/news/3258396-ocwen-now-down-40-investors-debate-endgame?source=tweet\" data-url=\"https://seekingalpha.com/news/3258396-ocwen-now-down-40-investors-debate-endgame\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258395\" data-ts=\"1492709118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258395-tesla-recalls-53k-vehicles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla recalls 53K vehicles</a></h4><ul>     <li>Tesla (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-1%</font>) issued a voluntary recall for around 53K vehicles built early last year for a brake issue, according to a CNBC report.</li>     <li>The recall action covers both Model S cars and Model X SUVs. 31K of the recalled cars are located in the U.S.</li>     <li>The story is developing. More details will be added as they become available.</li>     <li><strong>Update</strong>: TechCrunch <a href=\"https://techcrunch.com/2017/04/20/tesla-voluntarily-recalls-around-53k-2016-model-s-and-model-x-vehicles/\" target=\"_blank\">posted</a> the e-mail sent to Tesla owners impacted by the recall. A key portion is below.</li><li>\"Tesla recently discovered a potential manufacturing issue with the electric parking brakes installed on certain Model S and Model X vehicles that could prevent the parking brake from releasing. We do not believe this issue could ever lead to a safety concern for our customers, and we have not seen a single accident or injury relating to it. However, in order to be overly cautious, we are going to be proactively replacing these parts to ensure that no issues arise.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258395\" data-linked=\"Tesla recalls 53K vehicles\" data-tweet=\"$TSLA - Tesla recalls 53K vehicles https://seekingalpha.com/news/3258395-tesla-recalls-53k-vehicles?source=tweet\" data-url=\"https://seekingalpha.com/news/3258395-tesla-recalls-53k-vehicles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>175&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258391\" data-ts=\"1492708637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GCO\" target=\"_blank\">GCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258391-genesco-rallies-off-of-journeys-momentum\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genesco rallies off of Journeys momentum</a></h4><ul><li>Genesco (NYSE:<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a>) is&nbsp;<font color='green'>up 6.24%</font>&nbsp;on a glowing day for retail in general.</li><li>Genesco got an extra boost when Piper Jafffray analyst Erinn Murphy pointed out momentum for the Journeys brand is building heading into the back-to-school buying season. Piper now rates GCO at <a href=\"https://www.benzinga.com/news/17/04/9324504/15-biggest-mid-day-gainers-for-thursday\" target=\"_blank\">Overweight</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258361-retail-bellwether-foot-locker-helps-lift-sector\" target=\"_blank\">Retail bellwether Foot Locker helps to lift sector</a> (April 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258391\" data-linked=\"Genesco rallies off of Journeys momentum\" data-tweet=\"$GCO - Genesco rallies off of Journeys momentum https://seekingalpha.com/news/3258391-genesco-rallies-off-of-journeys-momentum?source=tweet\" data-url=\"https://seekingalpha.com/news/3258391-genesco-rallies-off-of-journeys-momentum\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258386\" data-ts=\"1492707729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258386-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KCG' title='KCG Holdings, Inc.'>KCG</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/SLM' title='SLM Corporation'>SLM</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ZAIS' title='ZAIS Group Holdings'>ZAIS</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/JCAP' title='Jernigan Capital'>JCAP</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/RLI' title='RLI Corp'>RLI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TCBI' title='Texas Capital Bancshares, Inc.'>TCBI</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258386\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$KCG $VIRT $SLM - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3258386-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258386-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258382\" data-ts=\"1492707116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCN\" target=\"_blank\">OCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258382-ocwen-crumbles-on-regulatory-issues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocwen crumbles on more regulatory issues</a></h4><ul><li>The North Carolina bank commissioner has issued a cease and desist order to Ocwen Financial (<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='red'>-12.8%</font>).</li><li>Altisource Portfolio Solutions (<a href='https://seekingalpha.com/symbol/ASPS' title='Altisource Portfolio Solutions SA'>ASPS</a> <font color='red'>-9.7%</font>), Altisource Residential (<a href='https://seekingalpha.com/symbol/RESI' title='Front Yard Residential Corporation'>RESI</a> <font color='red'>-2.9%</font>)</li><li>More details as they come in ...</li><li><strong>Update at 12:57 ET:</strong> <a href=\"http://nccob.gov/public/docs/News/Press%20Releases/OcwenOrder17_025.pdf\" target=\"_blank\">Link to order is here</a>. The order requires Ocwen to immediately cease acquiring new MSRs or originating new mortgages to be serviced by Ocwen until the company can show that it's financial stable, and that customer escrow funds are being properly accounted for and being disbursed in an accurate and timely fashion.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258382\" data-linked=\"Ocwen crumbles on more regulatory issues\" data-tweet=\"$OCN $OCN $ASPS - Ocwen crumbles on more regulatory issues https://seekingalpha.com/news/3258382-ocwen-crumbles-on-regulatory-issues?source=tweet\" data-url=\"https://seekingalpha.com/news/3258382-ocwen-crumbles-on-regulatory-issues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258381\" data-ts=\"1492706633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258381-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a> <font color='green'>+42%</font>. SCSS <font color='green'>+25%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>&nbsp;<font color='green'>+</font><font color='green'>23%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/SXC' title='SunCoke Energy'>SXC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/DWCH' title='Datawatch Corporation'>DWCH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/KCG' title='KCG Holdings, Inc.'>KCG</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> AUXO <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-10%</font>. APRI <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/AQMS' title='Aqua Metals'>AQMS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RLI' title='RLI Corp'>RLI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258381\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$IMNPQ $NADL $SNBR - Midday Gainers / Losers https://seekingalpha.com/news/3258381-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3258381-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258369\" data-ts=\"1492704060\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258369-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> SCSS <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/MSN' title='Emerson Radio Corp'>MSN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VNCE' title='Vince Holding Corp.'>VNCE</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/HY' title='Hyster-Yale Materials Handling, Inc.'>HY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NAV' title='Navistar International Corporation'>NAV</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DFBG-OLD' title='Differential Brands Group Inc.'>DFBG-OLD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='red'>-6%</font>. SPU <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258369\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SNBR $MSN $VNCE - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3258369-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3258369-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258359\" data-ts=\"1492703735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258359-tesaro-trips-on-zejula-price-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TESARO trips on Zejula price; shares down 11%</a></h4><ul><li>TESARO's (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-10.6%</font>) victory lap for the U.S. launch of PARP inhibitor <a href=\"http://zejula.com/\" target=\"_blank\">Zejula </a>(niraparib) has turned into a stumble out of the gate. Shares are down on more than a 75% spike in volume over investors' apparent trepidation with the price.</li><li>Yesterday, the company announced that Zejula's wholesales acquisition cost &#40;WAC&#41; will be $9,833/month or ~$118K/year, based on 200 mg/day. The recommended dose, per the <a href=\"http://zejula.com/docs/Zejula_%28niraparib%29_Full_Prescribing_Information.pdf\" target=\"_blank\">package insert</a>, is 300 mg/day, however, increasing the annual cost to ~$177,000 ($14,749.50/month). The bullish price is higher than Clovis Oncology's (<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color='green'>+2.6%</font>) Rubraca (rucaparib) at $165,000 ($13,750/mo.) and AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca Group plc'>AZN</a> <font color='green'>+0.7%</font>) Lynparza (olaparib) at <a href=\"https://www.ahip.org/wp-content/uploads/2016/04/HighPriceDrugsReport.pdf\" target=\"_blank\">$134,400 ($11,200/mo.)</a>.</li><li>TESARO chief <a href=\"https://endpts.com/tesaro-has-a-drug-pricing-game-for-you-to-play-today/\" target=\"_blank\">Lonnie Moulder says </a>the reason that the WAC was quoted at the 200 mg/day level is that most patients (69%) are down-dosed over the initial one-to-three months of treatment as the oncologist \"dials in\" the dose (31% remain at 300 mg/day).</li></ul><div class=\"tiny-share-widget\" data-id=\"3258359\" data-linked=\"TESARO trips on Zejula price; shares down 11%\" data-tweet=\"$TSRO $TSRO $CLVS - TESARO trips on Zejula price; shares down 11% https://seekingalpha.com/news/3258359-tesaro-trips-on-zejula-price-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3258359-tesaro-trips-on-zejula-price-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258361\" data-ts=\"1492703206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FL\" target=\"_blank\">FL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258361-retail-bellwether-foot-locker-helps-to-lift-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail bellwether Foot Locker helps to lift sector</a></h4><ul><li>A better-than-expected read from Foot Locker (<a href='https://seekingalpha.com/symbol/FL' title='Foot Locker, Inc.'>FL</a> <font color='green'>+5.1%</font>) on comparable sales in March and April is a shot in the arm to retail stocks</li><li>The excuse heard across the sector that late tax refunds impacted February sales is getting some validation from the Foot Locker numbers. There's also some favorable earnings reports and analyst upgrades that are helping to boost sentiment.</li><li>The S&amp;P Retail ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>) is&nbsp;<font color='green'>up 1.62%&nbsp;</font>on the day, compared to the&nbsp;<font color='green'>0.51% gain&nbsp;</font>for the S&amp;P 500 Index. Notable gainers include apparel sellers Destination XL Group (<a href='https://seekingalpha.com/symbol/DXLG' title='Destination XL Group, Inc.'>DXLG</a> <font color='green'>+5.9%</font>), Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='green'>+7.4%</font>), Express (<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='green'>+6.6%</font>), Genesco (<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a> <font color='green'>+5.4%</font>), Ascena Retail Group (<a href='https://seekingalpha.com/symbol/ASNA' title='Ascena Retail Group Inc'>ASNA</a> <font color='green'>+5.6%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='green'>+4.9%</font>), American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='green'>+4.8%</font>), Buckle (<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='green'>+4.7%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='green'>+2.7%</font>), J Jill (<a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a> <font color='green'>+1.1%</font>), Nordstrom (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a> <font color='green'>+3%</font>) and The Children's Place (<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a> <font color='green'>+3.3%</font>).</li><li>The rally is somewhat broad, with Wal-Mart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='green'>+1.1%</font>), Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='green'>+1.5%</font>), Staples (<a href='https://seekingalpha.com/symbol/SPLS' title='Staples, Inc.'>SPLS</a> <font color='green'>+1.7%</font>), Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='green'>+3.4%</font>) and Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color='green'>+2.3%</font>) also heading in the right direction.</li><li>Retail ETFs: <a href='https://seekingalpha.com/symbol/XLY' title='Consumer Discretionary Select Sector SPDR ETF'>XLY</a>, <a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>, <a href='https://seekingalpha.com/symbol/VCR' title='Vanguard Consumer Discretionary ETF'>VCR</a>, <a href='https://seekingalpha.com/symbol/RTH' title='VanEck Vectors Retail ETF'>RTH</a>, <a href='https://seekingalpha.com/symbol/RETL' title='Direxion Daily Retail Bull 3x Shares ETF'>RETL</a>, <a href='https://seekingalpha.com/symbol/FXD' title='First Trust Consumer Discretionary AlphaDEX ETF'>FXD</a>, <a href='https://seekingalpha.com/symbol/IYC' title='iShares U.S. Consumer Services ETF'>IYC</a>, <a href='https://seekingalpha.com/symbol/FDIS' title='Fidelity MSCI Consumer Discretionary Index ETF'>FDIS</a>, <a href='https://seekingalpha.com/symbol/SCC' title='ProShares UltraShort Consumer Services ETF'>SCC</a>, <a href='https://seekingalpha.com/symbol/RCD' title='Invesco S&P Equal Weight Consumer Discretionary ETF'>RCD</a>, <a href='https://seekingalpha.com/symbol/UCC' title='ProShares Ultra Consumer Services ETF'>UCC</a>, <a href='https://seekingalpha.com/symbol/PMR' title='Invesco Dynamic Retail Portfolio ETF'>PMR</a>, <a href='https://seekingalpha.com/symbol/CNDF' title='iShares Edge MSCI Multifactor Consumer Discretionary ETF'>CNDF</a>, <a href='https://seekingalpha.com/symbol/FTXD' title='First Trust Nasdaq Retail ETF'>FTXD</a>, <a href='https://seekingalpha.com/symbol/JHMC' title='John Hancock Multifactor Consumer Discretionary ETF'>JHMC</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258361\" data-linked=\"Retail bellwether Foot Locker helps to lift sector\" data-tweet=\"$FL $FL $XRT - Retail bellwether Foot Locker helps to lift sector https://seekingalpha.com/news/3258361-retail-bellwether-foot-locker-helps-to-lift-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3258361-retail-bellwether-foot-locker-helps-to-lift-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258358\" data-ts=\"1492702396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258358-vales-q1-iron-ore-output-hits-q1-record-down-6_7-q-q\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vale&#39;s Q1 iron ore output hits Q1 record but down 6.7% Q/Q</a></h4><ul>     <li>Vale (<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+4.7%</font>) says <a href=\"http://www.reuters.com/article/vale-sa-output-idUSL1N1HS0N3\" target=\"_blank\">Q1 iron ore production</a> totaled 86.2M metric tons, a 6.7% Q/Q decline but an 11.2% Y/Y gain and a Q1 record, as the S11D and Itabiritos projects ramped up.</li>     <li>Vale says its northern system, which groups the Caraj&aacute;s, Serra Leste and S11D mines in northern Brazil, produced a record 36M metric tons in Q1 despite heavy summer rains in the region.</li>     <li>Vale's global recovery metrics, a measure of iron ore extraction productivity, rose to 49% at the end of the quarter from 44% a year earlier.</li>     <li>Q1 trends indicate that ore production could come within guidance of 360M-380M metric tons this year; Vale also says output could reach a base target of 400M tons or more after 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258358\" data-linked=\"Vale&#39;s Q1 iron ore output hits Q1 record but down 6.7% Q/Q\" data-tweet=\"$VALE - Vale&#39;s Q1 iron ore output hits Q1 record but down 6.7% Q/Q https://seekingalpha.com/news/3258358-vales-q1-iron-ore-output-hits-q1-record-down-6_7-q-q?source=tweet\" data-url=\"https://seekingalpha.com/news/3258358-vales-q1-iron-ore-output-hits-q1-record-down-6_7-q-q\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258356\" data-ts=\"1492701506\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHI\" target=\"_blank\">DHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258356-investors-sell-news-on-d-r-horton-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors sell the news on D.R. Horton; shares down 2%</a></h4><ul><li>With the stock already ahead more than 20% YTD, investors may have already priced in a strong FQ2 report from D.R. Horton (<a href='https://seekingalpha.com/symbol/DHI' title='D. R. Horton Inc.'>DHI</a> <font color='red'>-2.1%</font>). There was a headline beat, but exclude a tax benefit, and EPS missed estimates, according to Bloomberg.</li><li>Wells Fargo bull Stephen East says operating margin of 10.5% (excl. impairment charge) was 10 basis points below his estimate. He reiterates his Outperform rating and $34-$36 price target range.</li><li>MKM's Megan McGrath says the company did what it needed to do with solid order growth and better-than-expected closings. She reiterates a Neutral rating and $33 price target.</li><li><a href='https://seekingalpha.com/symbol/ITB' title='iShares U.S. Home Construction ETF'>ITB</a>&nbsp;<font color='red'>-0.65%</font>, while the more retail-oriented (think Home Depot) <a href='https://seekingalpha.com/symbol/XHB' title='SPDR Homebuilders ETF'>XHB</a>&nbsp;<font color='green'>+0.2%</font></li><li>Previously: <a href=\"https://seekingalpha.com/news/3258237-d-r-horton-0_9-percent-earnings-beat-raised-guidance\" target=\"_blank\">D.R. Horton up 0.9% after earnings beat, raised guidance</a> (April 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258356\" data-linked=\"Investors sell the news on D.R. Horton; shares down 2%\" data-tweet=\"$DHI $DHI $ITB - Investors sell the news on D.R. Horton; shares down 2% https://seekingalpha.com/news/3258356-investors-sell-news-on-d-r-horton-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3258356-investors-sell-news-on-d-r-horton-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258354\" data-ts=\"1492701131\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWLD\" target=\"_blank\">BWLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258354-activist-pressure-sends-buffalo-wild-wings-to-4-month-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activist pressure sends Buffalo Wild Wings to 4-month high</a></h4><ul>          <li>Marcato Capital Management officially files its proxy statement on Buffalo Wild Wings (<a href='https://seekingalpha.com/symbol/BWLD' title='Buffalo Wild Wings, Inc.'>BWLD</a> <font color='green'>+4.3%</font>).</li>     <li>The activist firm nominates&nbsp;Scott Bergren, Sam Rovit, Lee Sanders and Mick McGuire to the BWLD board. The first three are restaurant industry execs, while McGuire is the managing partner at Marcato.</li>     <li>\"Simply put, the financial and operational performance of Buffalo Wild Wings over the past several years has been inexcusable.&nbsp; Shares have underperformed virtually every relevant benchmark on a 1-year, 3-year, and 5-year basis, and restaurant margins are at their lowest level since the financial crisis,\" maintains McGuire.</li>     <li>\"The status quo is unacceptable &ndash; oversight and accountability must be restored and CEO Sally Smith must be replaced,\" he adds.</li><li>Today's rally pushes Buffalo Wild Wings back over $160 for the first time since December.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258300-marcato-pushes-new-chief-buffalo-wild-wings\" target=\"_blank\">Marcato pushes for new chief at Buffalo Wild Wings</a> (April 20)</li><li>Source: <a href=\"https://seekingalpha.com/pr/16805096-marcato-files-definitive-proxy-materials-buffalo-wild-wings-2017-annual-meeting\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258354\" data-linked=\"Activist pressure sends Buffalo Wild Wings to 4-month high\" data-tweet=\"$BWLD - Activist pressure sends Buffalo Wild Wings to 4-month high https://seekingalpha.com/news/3258354-activist-pressure-sends-buffalo-wild-wings-to-4-month-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3258354-activist-pressure-sends-buffalo-wild-wings-to-4-month-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258353\" data-ts=\"1492700675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WABC\" target=\"_blank\">WABC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258353-westamerica-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Westamerica beats by $0.02, beats on revenue</a></h4><ul><li>Westamerica (NASDAQ:<a href='https://seekingalpha.com/symbol/WABC' title='Westamerica Bancorporation'>WABC</a>): Q1 EPS of $0.57 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $47.68M (-1.0% Y/Y) <font color='green'>beats by $1.35M</font>.</li><li>Shares <font color='green'>+1.6%</font>.</li><li><a href='https://seekingalpha.com/pr/16805264-westamerica-bancorporation-reports-first-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258353\" data-linked=\"Westamerica beats by $0.02, beats on revenue\" data-tweet=\"$WABC - Westamerica beats by $0.02, beats on revenue https://seekingalpha.com/news/3258353-westamerica-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3258353-westamerica-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258324\" data-ts=\"1492700439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258324-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/SIGA' title='SIGA Technologies Inc.'>SIGA</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/IMGN' title='ImmunoGen, Inc.'>IMGN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/CGIX' title='Cancer Genetics, Inc.'>CGIX</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='red'>-10%</font>. SKLN <font color='red'>-10%</font>. APRI <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258324\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$IMNPQ $SIGA $AKTX - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3258324-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3258324-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258347\" data-ts=\"1492699735\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BITA\" target=\"_blank\">BITA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258347-bitauto-raises-1b-from-china-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitauto raises $1B from China peers</a></h4><ul>   <li>Bitauto (<a href=\"http://seekingalpha.com/symbol/BITA\" target=\"_blank\">BITA</a> <font color='green'>+3.7%</font>) has new fodder for building out its car financing platform, with a <a href=\"http://www.reuters.com/article/us-autoshow-shanghai-bitauto-holdings-idUSKBN17M0L6\" target=\"_blank\">fresh $1B raised</a> from Tencent (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color='green'>+3.4%</font>), Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color='green'>+0.9%</font>) and JD.com (<a href=\"http://seekingalpha.com/symbol/JD\" target=\"_blank\">JD</a> <font color='green'>+1.8%</font>).</li>    <li>The company has the largest car-finance platform in China, where consumers traditionally avoid car loans. Deloitte expects 50% of cars to be bought on credit in China by 2020 (vs. about 80% in the U.S. today).</li>    <li>Bitauto is up 33.5% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258347\" data-linked=\"Bitauto raises $1B from China peers\" data-tweet=\"$BITA $BITA $TCEHY - Bitauto raises $1B from China peers https://seekingalpha.com/news/3258347-bitauto-raises-1b-from-china-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3258347-bitauto-raises-1b-from-china-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258345\" data-ts=\"1492699607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258345-trump-to-revive-1962-law-to-investigate-steel-imports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trump to revive 1962 law to investigate steel imports</a></h4><ul>     <li><a href=\"http://www.cnbc.com/2017/04/20/steel-stocks-climb-higher-as-trump-meets-with-industry-ceos.html\" target=\"_blank\">Steel stocks are higher</a> as Pres. Trump is expected to meet with industry executives today at the White House and sign a directive asking for a probe into whether imports of foreign-made steel are hurting U.S. national security.</li>     <li>Trump reportedly will sign the memorandum authorizing a probe under section 232 of the Trade Expansion Act of 1962, a rarely used law that allows emergency trade sanctions based on reasons of national  security.</li>     <li>Meanwhile, the U.S. International Trade Commission today will hear an <a href=\"https://www.bloomberg.com/news/articles/2017-04-20/u-s-steel-seeks-china-trade-probe-amid-trump-s-buy-america-push\" target=\"_blank\">antitrust complaint</a> from U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='green'>+3.8%</font>) that rival Chinese manufacturers colluded to fix prices to undercut competitors in the U.S. market; in  November, a trade judge rejected the claim, saying the agency did not have legal authority to hear the allegations.</li>     <li>Other steel-related stocks (<a href='https://seekingalpha.com/symbol/SLX' title='VanEck Vectors Steel ETF'>SLX</a> <font color='green'>+2.2%</font>) also are higher: <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='green'>+4.4%</font>, <a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+1.7%</font>, <a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a> <font color='green'>+4.1%</font>, <a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+3.3%</font>, <a href='https://seekingalpha.com/symbol/ATI' title='Allegheny Technologies Incorporated'>ATI</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/RS' title='Reliance Steel & Aluminum Co.'>RS</a> <font color='green'>+1.1%</font>, <a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='green'>+1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258345\" data-linked=\"Trump to revive 1962 law to investigate steel imports\" data-tweet=\"$X $X $SLX - Trump to revive 1962 law to investigate steel imports https://seekingalpha.com/news/3258345-trump-to-revive-1962-law-to-investigate-steel-imports?source=tweet\" data-url=\"https://seekingalpha.com/news/3258345-trump-to-revive-1962-law-to-investigate-steel-imports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>44&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258343\" data-ts=\"1492699428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHW\" target=\"_blank\">SHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258343-on-sherwin-williams-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Sherwin Williams&#39; Q1</a></h4><ul>     <li>Sherwin Williams (<a href='https://seekingalpha.com/symbol/SHW' title='The Sherwin-Williams Company'>SHW</a> <font color='green'>+2.4%</font>)&nbsp;reports same-store sales rose 7.5% in <a href=\"https://seekingalpha.com/pr/16804505-sherwin-williams-company-reports-2017-first-quarter-financial-results\" target=\"_blank\">Q1</a>.</li>     <li>Paint stores group net sales grew 12.1% to $1.81B.</li>     <li>Consumer group net sales down 10.7% to $337.5M.</li>     <li>Global Finishes group net sales increased 3.6% to $470.3M.</li>     <li>Latin America Coatings group net sales up 12.9% to $141.4M.</li>     <li>Gross margin rate declined 40 bps to 48.6%.</li>     <li>SG&amp;A expense rate improved 210 bps to 36.8%.</li>     <li><b>Q2 Guidance</b>: Net sales:&nbsp;mid to high single digit percentage growth;&nbsp;Diluted EPS: $4.15 to $4.35.</li>     <li><b>FY2017 Guidance</b>: Net sales:&nbsp;mid single digit percentage growth;&nbsp;Diluted EPS: $13.65 to $13.85.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258343\" data-linked=\"More on Sherwin Williams&#39; Q1\" data-tweet=\"$SHW - More on Sherwin Williams&#39; Q1 https://seekingalpha.com/news/3258343-on-sherwin-williams-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258343-on-sherwin-williams-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258338\" data-ts=\"1492699377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258338-interpace-jettisons-long-term-debt-for-convertible-notes-shares-ahead-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpace jettisons long-term debt for convertible notes; shares ahead 8%</a></h4><ul><li>Interpace Diagnostics (<a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='green'>+7.7%</font>) jumps on higher volume in response to its <a href=\"https://seekingalpha.com/pr/16804743-interpace-diagnostics-eliminates-long-term-secured-debt\" target=\"_blank\">announcement</a> that it has exchanged all of its outstanding long-term $9.34M secured debt associated with the RedPath acquisition with an institutional investor at 95 cents on the dollar ($8.9M).</li><li>Under the terms of the transaction, Interpace issued a $5.3M secured convertible note and a $3.5M secured note, subsequently exchanged for a $3.5M secured convertible note. The investor then fully converted the notes into shares of the company's common stock.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258338\" data-linked=\"Interpace jettisons long-term debt for convertible notes; shares ahead 8%\" data-tweet=\"$IDXG - Interpace jettisons long-term debt for convertible notes; shares ahead 8% https://seekingalpha.com/news/3258338-interpace-jettisons-long-term-debt-for-convertible-notes-shares-ahead-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3258338-interpace-jettisons-long-term-debt-for-convertible-notes-shares-ahead-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258342\" data-ts=\"1492699220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTX\" target=\"_blank\">INTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258342-intersections-jumps-to-52-week-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intersections jumps to 52-week high</a></h4><ul> <li>Shares of Intersections (NASDAQ:<a href='https://seekingalpha.com/symbol/INTX' title='Intersections, Inc.'>INTX</a>) <font color='green'>jump 10.81%</font> on volume already 3X normal trading activity.</li> <li>The consumer risk manager hit a 52-week high of $4.57. It's unclear what's prompting rally, although some traders are pointing at technical factors.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3258342\" data-linked=\"Intersections jumps to 52-week high\" data-tweet=\"$INTX - Intersections jumps to 52-week high https://seekingalpha.com/news/3258342-intersections-jumps-to-52-week-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3258342-intersections-jumps-to-52-week-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258339\" data-ts=\"1492698903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYS\" target=\"_blank\">CYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258339-cys-investments-leads-mreit-sector-higher-sell-side-stays-cautious\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CYS Investments leads mREIT sector higher; sell-side stays cautious</a></h4><ul><li>After a rough Q4, <a href=\"https://seekingalpha.com/news/3258057-cys-investments-performance-rebounds-q1-trades-premium-book\" target=\"_blank\">results at </a>CYS Investments (<a href='https://seekingalpha.com/symbol/CYS' title='CYS Investments, Inc.'>CYS</a> <font color='green'>+1.3%</font>) bounced nicely in the year's first three months, with earnings stronger than the dividend and book value dipping just slightly. The stock, however, now trades at a premium to book. Historians may want to check on the last time this occurred.</li><li>Not necessarily commenting on CYS (which was the first mREIT to report Q1), Deutsche's&nbsp;George Bahamondes says certain names in the sector should see increased net interest margin pressure for the remainder of the year. His top picks in commercial are Starwood (NYSE:<a href='https://seekingalpha.com/symbol/STWD' title='Starwood Property Trust, Inc.'>STWD</a>) and Blackstone Mortgage (NYSE:<a href='https://seekingalpha.com/symbol/BXMT' title='Blackstone Mortgage Trust, Inc.'>BXMT</a>), and in residential Two Harbors (NYSE:<a href='https://seekingalpha.com/symbol/TWO' title='Two Harbors Investment Corp.'>TWO</a>) and Redwood (NYSE:<a href='https://seekingalpha.com/symbol/RWT' title='Redwood Trust Inc'>RWT</a>).</li><li>JMP's Trevor Cranston expects mREITs (<a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a> <font color='green'>+0.2%</font>) to show pretty solid book value performance in Q1 thanks to more stable interest rates, and improved asset spreads.</li><li>KBW's Bose George reiterates his neutral-to-cautious stance thanks to an expected two more rate hikes this year and two more in 2018. He also takes note of Fed musings about balance sheet normalization which would likely hit MBS spreads. He's a fan of Two Harbors and New Residential (NYSE:<a href='https://seekingalpha.com/symbol/NRZ' title='New Residential Investment Corp.'>NRZ</a>), with both well-positioned for higher rates.</li><li>Reporting by Felice Maranz at Bloomberg</li><li>ETFs: <a href='https://seekingalpha.com/symbol/MORL' title='UBS ETRACS Monthly Pay 2x Leveraged Mortgage REIT ETN'>MORL</a>, <a href='https://seekingalpha.com/symbol/REM' title='iShares Mortgage Real Estate Capped ETF'>REM</a>, <a href='https://seekingalpha.com/symbol/MORT' title='VanEck Vectors Mortgage REIT Income ETF'>MORT</a></li><li>Annaly Capital (<a href='https://seekingalpha.com/symbol/NLY' title='Annaly Capital Management, Inc.'>NLY</a> flat), AGNC Investment (<a href='https://seekingalpha.com/symbol/AGNC' title='AGNC Investment Corp.'>AGNC</a> <font color='green'>+0.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258339\" data-linked=\"CYS Investments leads mREIT sector higher; sell-side stays cautious\" data-tweet=\"$CYS $CYS $STWD - CYS Investments leads mREIT sector higher; sell-side stays cautious https://seekingalpha.com/news/3258339-cys-investments-leads-mreit-sector-higher-sell-side-stays-cautious?source=tweet\" data-url=\"https://seekingalpha.com/news/3258339-cys-investments-leads-mreit-sector-higher-sell-side-stays-cautious\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258337\" data-ts=\"1492698620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258337-natural-gas-inventory-builds-in-last-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory builds in the last week</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+54&nbsp;</strong>Bcf vs. +48 Bcf consensus, +10 Bcf last week.</li><li>Futures&nbsp;<font color='red'>-0.47%</font>&nbsp;to $3.170.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258337\" data-linked=\"Natural gas inventory builds in the last week\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory builds in the last week https://seekingalpha.com/news/3258337-natural-gas-inventory-builds-in-last-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3258337-natural-gas-inventory-builds-in-last-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258336\" data-ts=\"1492698561\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258336-nucorplus-1_5-on-solid-q1-results-positive-q2-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor +1.5% on solid Q1 results, positive Q2 outlook</a></h4><ul>     <li>Nucor (<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='green'>+1.5%</font>) is higher after reporting <a href=\"https://seekingalpha.com/news/3258284-nucor-eps-line-beats-revenue\" target=\"_blank\">Q1 earnings</a> in-line with prior guidance and beating estimates on revenues, as it sees renewed demand growth in energy and non-residential construction markets.</li>     <li>NUE says Q1 earnings were the highest in recent years, and it expects Q2 earnings to improve vs. Q1, forecasting improved performance in its steel mills segment as metal margins expand at sheet mills due to the delayed  impact of contract pricing.</li>     <li>NUE says average sales price per ton rose 21% Y/Y and 8% Q/Q, with total tons shipped to outside customers of 6.58M tons up by 7% Y/Y and 13% Q/Q.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258336\" data-linked=\"Nucor +1.5% on solid Q1 results, positive Q2 outlook\" data-tweet=\"$NUE - Nucor +1.5% on solid Q1 results, positive Q2 outlook https://seekingalpha.com/news/3258336-nucorplus-1_5-on-solid-q1-results-positive-q2-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3258336-nucorplus-1_5-on-solid-q1-results-positive-q2-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258333\" data-ts=\"1492697884\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POOL\" target=\"_blank\">POOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258333-on-pool-corporations-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Pool Corporation&#39;s Q1</a></h4><ul>     <li>Pool (<a href='https://seekingalpha.com/symbol/POOL' title='Pool Corporation'>POOL</a> <font color='green'>+2.6%</font>)&nbsp;reports&nbsp;base business net sales growth of&nbsp;5% in <a href=\"https://seekingalpha.com/pr/16804509-pool-corporation-reports-record-first-quarter-results-updates-2017-earnings-guidance-range\" target=\"_blank\">Q1</a>.</li>     <li>Gross margin rate improved 30 bps to 28.1%.</li>     <li>SG&amp;A expense rate up 40 bps to 22.4%.</li>     <li>Operating margin rate remained constant Y/Y at 5.7%.</li>     <li>The company expects FY2017 diluted EPS to be in the range of $4.12 to $4.32.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3258333\" data-linked=\"More on Pool Corporation&#39;s Q1\" data-tweet=\"$POOL - More on Pool Corporation&#39;s Q1 https://seekingalpha.com/news/3258333-on-pool-corporations-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258333-on-pool-corporations-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258329\" data-ts=\"1492697566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMNP\" target=\"_blank\">IMNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258329-immune-pharma-finalizing-deal-for-commercialization-of-ceplene-in-latin-america-shares-ahead\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Pharma finalizing deal for commercialization of Ceplene in Latin America; shares ahead 59%</a></h4><ul><li>Thinly traded nano cap Immune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+59%</font>) jumps on a healthy 45x spike in volume in response to its <a href=\"https://seekingalpha.com/pr/16804671-immune-pharmaceuticals-signs-letter-intent-pint-pharma-regarding-license-commercializion\" target=\"_blank\">announcement </a>that it has inked a binding letter of intent &#40;LOI&#41; with Pint Pharma GmnH for the commercialization of Ceplene (histamine dihydrochloride)&nbsp;in Latin America. The LOI binds the parties to seek an agreement extending an exclusive license to Pint for all Latin American countries including Mexico.</li><li>In conjunction with the deal, Pint will make a $4M investment in IMNP subsidiary Cytovia.</li><li>Celpene is administered with low-dose interleukin-2 (IL-2) for the first remission maintenance treatment of patients with acute myeloid leukemia &#40;ALL&#41;.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258329\" data-linked=\"Immune Pharma finalizing deal for commercialization of Ceplene in Latin America; shares ahead 59%\" data-tweet=\"$IMNP $IMNPQ - Immune Pharma finalizing deal for commercialization of Ceplene in Latin America; shares ahead 59% https://seekingalpha.com/news/3258329-immune-pharma-finalizing-deal-for-commercialization-of-ceplene-in-latin-america-shares-ahead?source=tweet\" data-url=\"https://seekingalpha.com/news/3258329-immune-pharma-finalizing-deal-for-commercialization-of-ceplene-in-latin-america-shares-ahead\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258328\" data-ts=\"1492696942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URI\" target=\"_blank\">URI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258328-rate-pressure-hits-united-rentals-and-peers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rate pressure hits United Rentals and peers</a></h4><ul> <li>United Rentals (<a href='https://seekingalpha.com/symbol/URI' title='United Rentals, Inc.'>URI</a> <font color='red'>-5.7%</font>) trades lower after management's comments on rental rates rattles investors.</li> <li>\"While our rental rates remained under some pressure, they continue to support our reaffirmed standalone 2017 guidance for total revenue, adjusted EBITDA and capital spending, and our increased guidance for free cash flow,\" noted CEO Michael Kneeland.</li><li>The earnings beat by United Rentals is taking a back seat to the rate anxiety.</li> <li>Other leasing names showing losses include Herc Holdings (<a href='https://seekingalpha.com/symbol/HRI' title='Herc Holdings'>HRI</a> <font color='red'>-4.3%</font>), H&amp;H Equipment Services (<a href='https://seekingalpha.com/symbol/HEES' title='H&E Equipment Services, Inc.'>HEES</a> <font color='red'>-2.5%</font>), General Finance (<a href='https://seekingalpha.com/symbol/GFN' title='General Finance Corporation'>GFN</a> <font color='red'>-1.5%</font>) and Hertz Global (<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color='red'>-0.7%</font>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3258044-united-rentals-beats-0_12-beats-revenue\" target=\"_blank\">United Rentals beats by $0.12, beats on revenue</a> (April 19)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258328\" data-linked=\"Rate pressure hits United Rentals and peers\" data-tweet=\"$URI $URI $HRI - Rate pressure hits United Rentals and peers https://seekingalpha.com/news/3258328-rate-pressure-hits-united-rentals-and-peers?source=tweet\" data-url=\"https://seekingalpha.com/news/3258328-rate-pressure-hits-united-rentals-and-peers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258325\" data-ts=\"1492696647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DOV\" target=\"_blank\">DOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258325-morgan-stanley-dover-may-rally-after-q1-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley: Dover may rally after Q1 beat</a></h4><ul><li>While a strong quarter had been \"well flagged\" by management, \"there is no question\" that Dover's (<a href='https://seekingalpha.com/symbol/DOV' title='Dover Corp'>DOV</a> <font color='green'>+3.2%</font>) Q1 results and its 2017 forecast boost outperformed buy-side expectations, according to Morgan Stanley.</li><li>Analyst Nigel Coe: Expects shares to rally with ~5% outperformance today, sees strongest Q1 backlog since 2011, awaits commentary on CC regarding breadth of activity in North America Energy segment as well as what caused the sharp inflection in refrigeration bookings and progress on curing manufacturing efficiencies.</li><li>The firm rates DOV at Overweight with a $90 PT.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258224-dovers-q1\" target=\"_blank\">More on Dover's Q1</a> (Apr. 20 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258325\" data-linked=\"Morgan Stanley: Dover may rally after Q1 beat\" data-tweet=\"$DOV - Morgan Stanley: Dover may rally after Q1 beat https://seekingalpha.com/news/3258325-morgan-stanley-dover-may-rally-after-q1-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3258325-morgan-stanley-dover-may-rally-after-q1-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258320\" data-ts=\"1492696105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSR\" target=\"_blank\">WSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258320-whitestone-reit-9_4-on-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Whitestone REIT 9.4% on capital raise</a></h4><ul><li>Alongside <a href=\"https://seekingalpha.com/news/3258076-whitestone-reit-buying-two-texas-retail-centers\" target=\"_blank\">an agreement to </a>purchase two Texas retail centers for more than $200M, Whitestone REIT (NYSEMKT:<a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a>) sold <a href=\"https://seekingalpha.com/pr/16805094-whitestone-reit-announces-pricing-public-offering-common-shares\" target=\"_blank\">7M shares for $13 each</a> - net proceeds expected to be about $87.23M. The underwriters retain an option to buy another 1M shares at that price.</li><li>Shares are currently&nbsp;<font color='red'>down 9.4%</font>&nbsp;to $12.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258320\" data-linked=\"Whitestone REIT 9.4% on capital raise\" data-tweet=\"$WSR - Whitestone REIT 9.4% on capital raise https://seekingalpha.com/news/3258320-whitestone-reit-9_4-on-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3258320-whitestone-reit-9_4-on-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258319\" data-ts=\"1492695810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTG\" target=\"_blank\">MTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258319-mgic-investment-up-2-loan-losses-fall-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MGIC Investment up 2% as loan losses fall in Q1</a></h4><ul><li>Q1 net operating income of $117.1M or $0.31 per share vs. $76.1M and $0.19 one year ago. Estimates were for $0.24 per share.</li><li>Boosting Q1's results by $49M was positive development in primary loss reserves. Losses of $27.6M in Q1 were down from $85M a year ago. Delinquencies now just 3.62% of loans vs. 40.5% in Q4 and 4.51% a year ago.</li><li>New insurance written of $9.3B up 12% Y/Y. Insurance in force of $183.5B up 4.8%. Primary delinquent inventory of 45,349 loans down 18.4%. Annual persistency of 76.9% vs. 79.9%.</li><li>Consolidated risk-to-capital ratio of 11.6:1 vs. 13.8:1.</li><li>Book value per share of $7.75 up 12.5% Y/Y.</li><li><a href=\"http://mtg.mgic.com/\" target=\"_blank\">Conference call at 10 ET</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3258175-mgic-investment-beats-0_07-misses-revenue\" target=\"_blank\">MGIC Investment beats by $0.07, misses on revenue</a> (April 20)</li><li><a href='https://seekingalpha.com/symbol/MTG' title='MGIC Investment Corporation'>MTG</a>&nbsp;<font color='green'>+1.9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3258319\" data-linked=\"MGIC Investment up 2% as loan losses fall in Q1\" data-tweet=\"$MTG - MGIC Investment up 2% as loan losses fall in Q1 https://seekingalpha.com/news/3258319-mgic-investment-up-2-loan-losses-fall-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3258319-mgic-investment-up-2-loan-losses-fall-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258304\" data-ts=\"1492694947\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258304-verizonminus-2_2-core-wireless-customers-drop-for-first-time\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Verizon -2.2% as core wireless customers drop for first time</a></h4><ul>   <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) is <font color='red'>off 2.2%</font> premarket after a first: losing core subscribers in a quarter for the first time ever, in <a href=\"https://seekingalpha.com/news/3258212-verizon-misses-0_01-misses-revenue\" target=\"_blank\">Q1 earnings results</a> that missed analyst expectations as revenue flagged.</li>    <li>Revenues fell 7.3% on a headline basis; excluding divestitures and acquisitions, it fell 4.5%. EBITDA was $11.2B, missing an expected $11.26B.</li>    <li>Retail postpaid connections were down a net 307,000, including 289,000 losses in phones; that decline was mitigated mid-quarter by the introduction of its unlimited plans, Verizon notes. Before those plans were rolled out, retail postpaid phone net losses were 389,000.</li>    <li>Retail postpaid churn was 1.15%, and retail postpaid connections grew 1.2% to 108.5M. It added 49,000 net smartphones to the base. Retail prepaid connections were up 0.5% to 5.4M.</li>    <li>Wireline revenues were off 0.6% to $7.9B; FiOS revenues were up 4.7% to $2.9B, chiefly driven by business markets.</li>    <li>For 2017, it expects organic revenues consistent with 2016, with improvement in wireless service revenue and equipment revenue trends. Capex expected at $16.8B-$17.5B, with an effective tax rate of 34-36%.</li>    <li><a href=\"https://seekingalpha.com/article/4063686-verizon-communications-2017-q1-results-earnings-call-slides\" target=\"_blank\">Earnings slides</a></li>    <li><a href=\"https://seekingalpha.com/pr/16804564-verizon-1q-results-highlighted-strong-wireless-customer-loyalty-network-investment-growth-new\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258304\" data-linked=\"Verizon -2.2% as core wireless customers drop for first time\" data-tweet=\"$VZ - Verizon -2.2% as core wireless customers drop for first time https://seekingalpha.com/news/3258304-verizonminus-2_2-core-wireless-customers-drop-for-first-time?source=tweet\" data-url=\"https://seekingalpha.com/news/3258304-verizonminus-2_2-core-wireless-customers-drop-for-first-time\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258303\" data-ts=\"1492694894\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECC\" target=\"_blank\">ECC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258303-eagle-point-credit-down-5_5-after-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Point Credit down 5.5% after capital raise</a></h4><ul><li>Net proceeds should be about $24.9M<a href=\"https://seekingalpha.com/pr/16805017-eagle-point-credit-company-inc-prices-offering-common-stock\" target=\"_blank\"> after the sale</a> of 1.35M shares of common stock for $19.50 each.</li><li>The underwriters have a greenshoe option to buy another 202.5K shares at that price.</li><li><a href='https://seekingalpha.com/symbol/ECC' title='Eagle Point Credit Company Inc.'>ECC</a>&nbsp;<font color='red'>-5.45%</font>&nbsp;to $19.38</li></ul><div class=\"tiny-share-widget\" data-id=\"3258303\" data-linked=\"Eagle Point Credit down 5.5% after capital raise\" data-tweet=\"$ECC - Eagle Point Credit down 5.5% after capital raise https://seekingalpha.com/news/3258303-eagle-point-credit-down-5_5-after-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3258303-eagle-point-credit-down-5_5-after-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258299\" data-ts=\"1492694605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGEN\" target=\"_blank\">AGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258299-agenus-launches-phase-1-2-study-of-pdminus-1-inhibitor-agen2034-in-advanced-tumors-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Agenus launches Phase 1/2 study of PD-1 inhibitor AGEN2034 in advanced tumors and cervical cancer; shares ahead 4% premarket</a></h4><ul><li>Micro cap Agenus (NASDAQ:<a href='https://seekingalpha.com/symbol/AGEN' title='Agenus'>AGEN</a>) is up&nbsp;<font color='green'>4%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16804861-phase-1-2-clinical-trial-agenus-anti-pdminus-1-antibody-begins\" target=\"_blank\">announcement </a>that the first patient has been dosed in a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03104699?term=agen2034&amp;rank=1\" target=\"_blank\">Phase 1/2 clinical trial</a> assessing anti-PD-1 antibody AGEN2034 in ~75 patients with advanced solid tumors and cervical cancer. The co-primary endpoints are safety (dose-limiting toxicities and maximum tolerated dose) and best overall response.</li><li>According to ClinicalTrials.gov, the estimated final data collection date for the primary endpoints is March 2019. The estimated study completion date is September 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258299\" data-linked=\"Agenus launches Phase 1/2 study of PD-1 inhibitor AGEN2034 in advanced tumors and cervical cancer; shares ahead 4% premarket\" data-tweet=\"$AGEN - Agenus launches Phase 1/2 study of PD-1 inhibitor AGEN2034 in advanced tumors and cervical cancer; shares ahead 4% premarket https://seekingalpha.com/news/3258299-agenus-launches-phase-1-2-study-of-pdminus-1-inhibitor-agen2034-in-advanced-tumors-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3258299-agenus-launches-phase-1-2-study-of-pdminus-1-inhibitor-agen2034-in-advanced-tumors-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258295\" data-ts=\"1492694160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXP\" target=\"_blank\">AXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258295-amexplus-2_3-after-earnings-analysts-weigh-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmEx +2.3% after earnings; analysts weigh in</a></h4><ul><li>via Bloomberg</li><li>A middle-of-the-roader on the stock, Morgan Stanley's Betsy Graseck acknowledges improving revenue growth, but says American Express (NYSE:<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a>) will likely need to continue paying for that growth with another boost in promotional offerings next year. She lifts her price target to $85 from $83.</li><li>Nomura's Bill Carcache reiterates his Reduce rating and $63 price target. The stock should do well today, but he figures at least some of the beat was driven by non-recurring items like record Q4 investment spending, and unsustainable cuts in marketing and promotion.</li><li>Another bear on the name, RBC's Jason Arnold says not to forget the boost to Q1 provided by a lower tax rate. Heated competition means marketing/rewards expense pressure isn't going anywhere. He lifts his PT to $63 from $60.</li><li>A bull on AmEx, Bernstein's Kevin St. Pierre says robust adjusted revenue growth bolsters his case, with 12%-plus EPS growth doable beyond this year. He lifts his PT to a Street-high $95.</li><li>Shares&nbsp;<font color='green'>+2.3%</font>&nbsp;premarket to $77.29.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258037-amex-rises-2_2-percent-earnings-beat\" target=\"_blank\">AmEx rises 2.2% after earnings beat</a> (April 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3258295\" data-linked=\"AmEx +2.3% after earnings; analysts weigh in\" data-tweet=\"$AXP - AmEx +2.3% after earnings; analysts weigh in https://seekingalpha.com/news/3258295-amexplus-2_3-after-earnings-analysts-weigh-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3258295-amexplus-2_3-after-earnings-analysts-weigh-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258294\" data-ts=\"1492694073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258294-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+76%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16804671-immune-pharmaceuticals-signs-letter-intent-pint-pharma-regarding-license-commercializion\" target=\"_blank\">entering </a>into a letter of intent with Pint Pharma regarding license and commercialization of Ceplene in Latin America.</li><li><a href='https://seekingalpha.com/symbol/IDXG' title='Interpace Diagnostics Group, Inc.'>IDXG</a> <font color='green'>+17%</font>&nbsp;on converting all of the remaining long-term secured outstanding debt into common stock.</li><li><a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a> <font color='green'>+16%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/16804513-oral-presentation-easl-highlights-contravir-s-tenofovir-exalidex-txl-antiviral-activity\" target=\"_blank\">announcing</a> new data demonstrating clinical antiviral activity, as well as safety and pharmacokinetic data of tenofovir exalidex.</li><li>SCSS <font color='green'>+13%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3258029-select-comfort-beats-0_12-beats-revenue\" target=\"_blank\">earnings</a> beat.</li><li><a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+13% </font>on <a href=\"https://seekingalpha.com/pr/16804638-saexploration-announces-20-million-new-project-awards\" target=\"_blank\">announcing</a> $20M of new project awards.</li><li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/VIRT' title='Virtu Financial, Inc.'>VIRT</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16804684-aldeyra-therapeutics-inc-receives-orphan-drug-designation-u-s-food-drug-administration\" target=\"_blank\">granting</a> Aldeyra's novel compound ADX-102 orphan drug designation for the treatment of congenital ichthyosis.</li><li><a href='https://seekingalpha.com/symbol/CSX' title='CSX Corporation'>CSX</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16804624-csx-corporation-announces-dividend-increase-new-share-repurchase-program-full-year-guidance\" target=\"_blank\">announcing</a> full year guidance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258294\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$IMNPQ $IDXG $HEPA - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3258294-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3258294-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258293\" data-ts=\"1492693949\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDX\" target=\"_blank\">ALDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258293-aldeyras-adxminus-102-orphan-drug-for-rare-skin-disease-shares-ahead-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aldeyra&#39;s ADX-102 an Orphan Drug for rare skin disease; shares ahead 6% premarket</a></h4><ul><li>Thinly traded nano cap Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16804684-aldeyra-therapeutics-inc-receives-orphan-drug-designation-u-s-food-drug-administration\" target=\"_blank\">announcement</a> that the FDA has designated ADX-102 an Orphan Drug for the treatment of Sj&ouml;gren-Larsson Syndrome, a rare inherited disorder characterized by dry scaly skin that results from the buildup of aldehydes in the body.</li><li><a href=\"http://www.aldeyra.com/for-physicians/\" target=\"_blank\">ADX-102</a>&nbsp;is an aldehyde-binding molecule or aldehyde trap. By decreasing aldehyde load, it may mitigate excessive inflammation caused by excess aldehydes. A Phase 3 study is on tap for later this year.</li><li>Among the benefits of Orphan Drug status is a seven-year period of market exclusivity for the indication, if approved.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258293\" data-linked=\"Aldeyra&#39;s ADX-102 an Orphan Drug for rare skin disease; shares ahead 6% premarket\" data-tweet=\"$ALDX - Aldeyra&#39;s ADX-102 an Orphan Drug for rare skin disease; shares ahead 6% premarket https://seekingalpha.com/news/3258293-aldeyras-adxminus-102-orphan-drug-for-rare-skin-disease-shares-ahead-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258293-aldeyras-adxminus-102-orphan-drug-for-rare-skin-disease-shares-ahead-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258292\" data-ts=\"1492693938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258292-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul> <li>SKLN <font color='red'>-11%</font>.</li><li><a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='red'>-11%</font>.</li><li><a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color='red'>-7%</font> on <a href=\"https://seekingalpha.com/pr/16804132-whitestone-reit-announces-proposed-offering-common-shares\" target=\"_blank\">offering</a> 8.1M shares.</li><li><a href='https://seekingalpha.com/symbol/WR' title='Westar Energy, Inc.'>WR</a> <font color='red'>-7%</font> on <a href=\"https://seekingalpha.com/news/3258098-westar-energy-takeover-great-plains-denied-kansas-regulator\" target=\"_blank\">disapproval of takeover</a> by  Corporation  Commission.</li><li><a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3258292\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$POAI $CBLI $WSR - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3258292-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3258292-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258284\" data-ts=\"1492693437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUE\" target=\"_blank\">NUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258284-nucor-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nucor EPS in-line, beats on revenue</a></h4><ul><li>Nucor (NYSE:<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a>): Q1 EPS of $1.13 in-line.</li><li>Revenue of $4.82B (+29.6% Y/Y) <font color='green'>beats by $190M</font>.</li><li>Shares <font color='green'>+1.9%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16804902-nucor-reports-results-first-quarter-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258284\" data-linked=\"Nucor EPS in-line, beats on revenue\" data-tweet=\"$NUE - Nucor EPS in-line, beats on revenue https://seekingalpha.com/news/3258284-nucor-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3258284-nucor-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258277\" data-ts=\"1492693226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258277-heard-during-select-comfort-earnings-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heard during the Select Comfort earnings call</a></h4><ul> <li>The news is good for the mattress sector after Select Comfort (SCSS) CEO Shelly Ibach painted a rosy picture during the firm's conference call on demand from consumers and their willingness to pay up for mattress innovation.</li> <li>\"We experienced strong consumer demand for our life-changing innovations. Our average revenue per mattress unit was up 2% in the quarter as we continue to grow our FlexFit Bed adjustable base business with strong mix,\" she noted.</li> <li>\"We have increased our full year 2017 earnings guidance to a range of $1.25 to $1.50 per share. We are confident in our ability to deliver on our plans and continue to make the necessary progress towards our 2019 EPS target of $2.75,\" said Ibach.</li> <li><a href=\"https://seekingalpha.com/article/4063581-select-comfort-corporations-scss-ceo-shelly-ibach-q1-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">Select Comfort earnings call transcript</a></li> <li>Select Comfort is <font color='green'>up 13.65%</font> premarket. Peer Tempur Sealy (NYSE:<a href='https://seekingalpha.com/symbol/TPX' title='Tempur Sealy International Inc.'>TPX</a>) is <font color='green'>3.14% higher.</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3258277\" data-linked=\"Heard during the Select Comfort earnings call\" data-tweet=\"$SNBR $SNBR $TPX - Heard during the Select Comfort earnings call https://seekingalpha.com/news/3258277-heard-during-select-comfort-earnings-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3258277-heard-during-select-comfort-earnings-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258275\" data-ts=\"1492693140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGX\" target=\"_blank\">DGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258275-quest-diagnostics-non-gaap-eps-up-18-in-q1-shares-ahead-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quest Diagnostics non-GAAP EPS up 18% in Q1; shares ahead 3% premarket</a></h4><ul><li>Quest Diagnostics (<a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a> <font color='green'>+1%</font>) <a href=\"https://seekingalpha.com/pr/16804458-quest-diagnostics-reports-first-quarter-2017-financial-results-raises-2017-financial-outlook\" target=\"_blank\">Q1 results</a>: Revenues: $1,899M (+1.9%); Operating Income: $279M (+8.6%); Net Income: $164M (+59.2%); EPS: $1.16 (+63.4%); Non-GAAP EPS: $1.33 (+17.7%); Quick Assets: $367M (+2.2%); CF Ops: $196M (+28.1%).</li><li><strong>2017 Guidance</strong>: Revenues: $7.64B - 7.72B (unch); GAAP EPS: $4.73 - 4.88 from $4.65 - 4.80; Non-GAAP EPS: $5.45 - 5.60 from $5.37 - 5.52; CF Ops: ~$1.1B (unch); CAPEX: $250M - 300M (unch).</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258275\" data-linked=\"Quest Diagnostics non-GAAP EPS up 18% in Q1; shares ahead 3% premarket\" data-tweet=\"$DGX - Quest Diagnostics non-GAAP EPS up 18% in Q1; shares ahead 3% premarket https://seekingalpha.com/news/3258275-quest-diagnostics-non-gaap-eps-up-18-in-q1-shares-ahead-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258275-quest-diagnostics-non-gaap-eps-up-18-in-q1-shares-ahead-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258272\" data-ts=\"1492692964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RDHL\" target=\"_blank\">RDHL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258272-redhills-yeliva-shows-treatment-effect-in-early-stage-cancer-study-shares-ahead-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RedHill&#39;s Yeliva shows treatment effect in early-stage cancer study; shares ahead 2% premarket</a></h4><ul><li>Thinly traded micro cap RedHill Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/RDHL' title='RedHill Biopharma Ltd.'>RDHL</a>) perks up&nbsp;<font color='green'>2%</font>&nbsp;premarket, albeit on only 5,900 shares, in response to its <a href=\"https://seekingalpha.com/pr/16804519-redhill-biopharma-announces-peer-reviewed-publication-positive-yeliva-phase-study-results\" target=\"_blank\">announcement </a>of positive data from a Phase 1 study in 21 patients with advanced solid tumors who were treated with YELIVA (ABC294640). The results were just published in the journal <em>Clinical Cancer Research</em>.</li><li>The open-label, dose-escalation trial, conducted at the Medical University of South Carolina, showed YELIVA was well-tolerated with one partial responder (cholangiocarcinoma) and six patients with stable disease.</li><li>Orally available YELIVA inhibits an enzyme called sphingosine kinase-2 (SK2). Blocking the activity of SK2 interferes with the synthesis of a lipid called sphingosine 1-phosphate (S1P) which promotes cancer growth and inflammation.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258272\" data-linked=\"RedHill&#39;s Yeliva shows treatment effect in early-stage cancer study; shares ahead 2% premarket\" data-tweet=\"$RDHL - RedHill&#39;s Yeliva shows treatment effect in early-stage cancer study; shares ahead 2% premarket https://seekingalpha.com/news/3258272-redhills-yeliva-shows-treatment-effect-in-early-stage-cancer-study-shares-ahead-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258272-redhills-yeliva-shows-treatment-effect-in-early-stage-cancer-study-shares-ahead-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258270\" data-ts=\"1492692494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BJRI\" target=\"_blank\">BJRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258270-bjs-restaurants-higher-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BJ&#39;s Restaurants higher after upgrade</a></h4><ul> <li>Wedbush lifts BJ's Restaurants (NASDAQ:<a href='https://seekingalpha.com/symbol/BJRI' title='BJ&#39;s Restaurants, Inc.'>BJRI</a>) to a Neutral rating after having the restaurant stock set at Underperform.</li> <li>BJ's is due to report Q1 earnings on April 27.</li>   <li>Shares of BJ's are <font color='green'>up 1.33%</font> premarket to $41.80 vs. a 52-week trading range of $32.24 to $47.55.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258270\" data-linked=\"BJ&#39;s Restaurants higher after upgrade\" data-tweet=\"$BJRI - BJ&#39;s Restaurants higher after upgrade https://seekingalpha.com/news/3258270-bjs-restaurants-higher-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3258270-bjs-restaurants-higher-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258269\" data-ts=\"1492692455\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KCG\" target=\"_blank\">KCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258269-kcg-holdings-eps-of-0_05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KCG Holdings EPS of $0.05</a></h4><ul><li>KCG Holdings (NYSE:<a href='https://seekingalpha.com/symbol/KCG' title='KCG Holdings, Inc.'>KCG</a>): Q1 EPS of $0.05 may not be comparable to consensus of -$0.04.</li><li>Revenue of $255.37M (-26.1% Y/Y) <font color='red'>misses by $3.63M</font>.</li><li>Shares <font color='green'>+11%</font> PM.</li><li><a href=\"https://seekingalpha.com/filing/3508959\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3258269\" data-linked=\"KCG Holdings EPS of $0.05\" data-tweet=\"$KCG - KCG Holdings EPS of $0.05 https://seekingalpha.com/news/3258269-kcg-holdings-eps-of-0_05?source=tweet\" data-url=\"https://seekingalpha.com/news/3258269-kcg-holdings-eps-of-0_05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258266\" data-ts=\"1492692254\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNBR\" target=\"_blank\">SNBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258266-select-comfort-soars-after-comparable-sales-shine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Select Comfort soars after comparable sales shine</a></h4><ul> <li>Select Comfort (SCSS) races higher after Q1 revenue tops estimates.</li> <li>Comparable sales were up 3% to sail past the -1.9% mark expected by analysts. The extra sales leverage helped the company lift its operating income 350 bps to 9.1% of sales.</li> <li>\"Consumers are responding enthusiastically to our brand and differentiated products,\" says CEO Shelly Ibach.</li> <li>Analysts are still cautious on the retailer, with Bank of America Merrill Lynch saying now is not the time for an investor to jump in and Keybanc warning on mattress trends (per NotableCalls</a>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3258029-select-comfort-beats-0_12-beats-revenue\" target=\"_blank\">Select Comfort beats by $0.12, beats on revenue</a> (April 19)</li> <li>SCSS <font color='green'>+14.61%</font> premarket to $29.65 vs. a 52-week trading range of $17.95 to $28.34.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258266\" data-linked=\"Select Comfort soars after comparable sales shine\" data-tweet=\"$SNBR - Select Comfort soars after comparable sales shine https://seekingalpha.com/news/3258266-select-comfort-soars-after-comparable-sales-shine?source=tweet\" data-url=\"https://seekingalpha.com/news/3258266-select-comfort-soars-after-comparable-sales-shine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258260\" data-ts=\"1492691752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRV\" target=\"_blank\">CTRV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258260-contravirs-txl-shows-treatment-effect-in-mid-stage-hbv-study-shares-ahead-21-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ContraVir&#39;s TXL shows treatment effect in mid-stage HBV study; shares ahead 21% premarket</a></h4><ul><li>Micro cap ContraVir Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRV' title='ContraVir Pharmaceuticals, Inc.'>CTRV</a>) is up&nbsp;<font color='green'>21%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16804513-oral-presentation-easl-highlights-contravir-s-tenofovir-exalidex-txl-antiviral-activity\" target=\"_blank\">announcement</a> of positive results from a Phase 2a clinical trial assessing tenofovir exalidex &#40;TXL&#41; in patients with chronic hepatitis B virus &#40;HBV&#41; infection. The data are being presented today at The International Liver Congress in Amsterdam.</li><li>Preliminary results showed treatment with TXL for 21 days resulted in a mean HBV viral load of 3,630 copies/mL compared to a mean viral load of 3,750 copies/mL for Gilead Sciences' Viread (tenofovir disoproxil fumarate). The reduction in viral load persisted for up to one month after stopping therapy. Levels <a href=\"http://www.hepb.org/blog/diagnosed-with-chronic-hepatitis-b-what-does-your-hbv-dna-test-tell-you/\" target=\"_blank\">below ~11,000 copies/mL</a> generally do not require treatment.</li><li>There were no serious adverse events (SAEs) observed and no discontinuations due to AEs.</li><li>TXL is a prodrug of the antiviral compound tenofovir. The company says its novel structure decreases the circulating levels of tenofovir which reduces the potential for renal toxicity. It adds that TXL can be a key component of a curative combination therapy for HBV.</li></ul><div class=\"tiny-share-widget\" data-id=\"3258260\" data-linked=\"ContraVir&#39;s TXL shows treatment effect in mid-stage HBV study; shares ahead 21% premarket\" data-tweet=\"$CTRV $HEPA - ContraVir&#39;s TXL shows treatment effect in mid-stage HBV study; shares ahead 21% premarket https://seekingalpha.com/news/3258260-contravirs-txl-shows-treatment-effect-in-mid-stage-hbv-study-shares-ahead-21-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3258260-contravirs-txl-shows-treatment-effect-in-mid-stage-hbv-study-shares-ahead-21-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258259\" data-ts=\"1492691585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAEX\" target=\"_blank\">SAEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258259-saexplorationplus-14-on-20m-in-new-project-awards\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SAExploration +14% on $20M in new project awards</a></h4><ul>     <li>SAExploration (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color='green'>+14.4%</font> premarket after announcing <a href=\"https://seekingalpha.com/pr/16804638-saexploration-announces-20-million-new-project-awards\" target=\"_blank\">~$20M in new project awards</a> for onshore  logistical support and seismic data acquisition services.</li>     <li>SAEX says the projects are located in Colombia and Canada and \"will cover different yet equally challenging terrain and require specialized knowledge of the surrounding environments.\"</li>     <li>SAEX says expects the projects to be performed  during H2 and will require no new capital spending.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258259\" data-linked=\"SAExploration +14% on $20M in new project awards\" data-tweet=\"$SAEX - SAExploration +14% on $20M in new project awards https://seekingalpha.com/news/3258259-saexplorationplus-14-on-20m-in-new-project-awards?source=tweet\" data-url=\"https://seekingalpha.com/news/3258259-saexplorationplus-14-on-20m-in-new-project-awards\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3258249\" data-ts=\"1492690942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PM\" target=\"_blank\">PM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3258249-philip-morris-down-on-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Philip Morris down on earnings miss</a></h4><ul>     <li>Philip Morris (NYSE:<a href='https://seekingalpha.com/symbol/PM' title='Philip Morris International Inc.'>PM</a>) reports revenue rose 1.7%&nbsp;if the impact of the currency swings is backed out in&nbsp;<a href=\"https://seekingalpha.com/pr/16804511-philip-morris-international-inc-pmi-reports-2017-first-quarter-results-increases-favorable\" target=\"_blank\">Q1</a>.</li>     <li>European Union revenue fell 7.9% to $1.71B.</li>     <li>Eastern Europe,&nbsp;Middle East&nbsp;&amp;&nbsp;Africa revenue declined 2.1% to $1.47B.</li>     <li>Asia revenue slipped 6% to $1.85B.</li>     <li>Latin America &amp; Canada revenue decreased 3.5% to $605M.</li>     <li>Cigarette shipment volume dropped 11.5% to 173.55B units.</li>     <li>The brands with the highest cigarette shipment volume growth for the quarter were&nbsp;Chesterfield +13.4% and Philip Morris +15.2%.</li>     <li>Gross margin rate squeezed 20 bps to 23.5%.</li>     <li>The company expects cigarette and heated tobacco unit volume decline of 3% to 4% for FY2017.</li>     <li>PM&nbsp;<font color='red'>-2.12%</font>&nbsp;premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3258249\" data-linked=\"Philip Morris down on earnings miss\" data-tweet=\"$PM - Philip Morris down on earnings miss https://seekingalpha.com/news/3258249-philip-morris-down-on-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3258249-philip-morris-down-on-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}